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ABSTRACT 
Targeted delivery of siRNA to human cancer and human embryonic stem cells with 
cell level resolution 
by 
Xiao Huang 
RNA interference (RNAi), a process that can silence specific genes, has been 
recognized for its potential in applications from basic research, cancer therapy to 
tissue engineering. However, the routine use of RNAi for disease treatment or 
prevention still calls for novel and efficient methods of delivery with targeting 
control. We recently developed an approach using hollow gold nanoshells (HGNs) 
and near-infrared (NIR) light: siRNAs loaded on HGNs via gold-thiol bonds are 
internalized in cells through targeting peptide-mediated pathways; laser 
illumination at a wavelength resonant with the nanoparticle plasmon (~800nm) 
triggers the release of siRNAs from gold surface to cytosol without any cell 
damage. A cancer-therapeutic siRNA (under phase I/II clinical trial) targeting Polo-
like kinase (plk1) gene is delivered via this strategy to specifically target human 
prostate cancer cells. We demonstrated that this method has no off-target toxicity to 
non-cancerous prostate cells, and requires 10-fold less material than standard 
transfection methods.  
Human embryonic stem cells (hESC) hold immense promise in tissue 
engineering due to their ability to differentiation into all types of cells, and RNAi 
 xi 
can serve as a powerful tool to attain this. We developed our HGN-based construct 
for effective cell penetration and optimized the protocol to accommodate delivery 
into hESCs. The effectiveness and biocompatibility of this light-activated RNAi 
approach were demonstrated by targeting GFP and Oct4 genes in hESCs, and no 
adverse effects to differentiation were detected.  
The in vitro generation of tissues and organs for transplantation therapy and 
disease models for drug screening demand proficient control over the three-
dimensional (3D) patterning of gene regulation. The exquisite activation of siRNA 
activity by tissue penetrable NIR light irradiation in our technique is well suited for 
this purpose. We used a two-photon microscope to discriminate targeted cell(s) 
from neighboring cell(s) by simply focusing NIR light at selected x, y and z 
position to activate the siRNA. The ability to induce light-mediated gene 
knockdown persists for at least two days, offering a time window for temporal 
control.  
Furthermore, we developed a universal surface module for the maximized 
delivery of short functional nucleic acids in versatile mammalian cell lines. A 
modular biotin-modified thiol-RNA is designed as the scaffold for streptavidin and 
biotin-TAT attaching, sharing the surface with thiolated functional RNA. We found 
interesting surface chemistries with direct impact on cellular delivery outcomes. 
This should provide an important basis for various cell engineering applications. 
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I. Introduction 
A. RNA interference 
RNA interference (RNAi) is a process of sequence specific post-
transcriptional gene silencing initiated by double-stranded RNA (dsRNA, ~20-
25bp). It was first described in Caenorhabditis elegans in 1998 [1], where long 
dsRNA injected into adult animals silenced the expression of genes with sequence 
homology to the dsRNA [2, 3]. Subsequently, similar phenomena were described in 
Drosophila melanogaster, plants and undifferentiated mammalian cells [2, 4, 5]. As 
dsRNA is introduced into the cytoplasm, it is processed by an RNase III enzyme, 
Dicer, into 21-nucleotide (nt) dsRNAs with 2-nt 3’ overhangs, termed small 
interfering RNA (siRNA) [6, 7]. SiRNAs are assembled into the RNA-induced 
silencing complex (RISC), which mediates the degradation of complementary 
mRNAs, silencing certain gene expression [3, 8]. Initially, people believed that 
nonspecific activation of the antiviral response by dsRNA longer than 30nt would 
deter the use of RNAi as a therapeutic tool in mammals [4, 9, 10]. However, Tushl 
and Caplen et al. [9, 10] reported the delivery of siRNAs to the cytoplasm of 
mammalian cells that efficiently mediated gene down-regulation. Importantly, 
introduction of synthetic RNA duplex with perfect homology to the target gene 
predominantly results in its degradation, thus siRNA emerged as a new tool for 
regulating specific gene expression [11]. It is being used to investigate the 
properties of known or suspected factors that play a role in oncogenesis, to discover 
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the new modulators of this process and is considered as an option for the therapy of 
diseases and cancers [11]. As a therapeutic approach, RNAi provides solutions to 
the major drawbacks of traditional pharmaceutical drugs that all targets, including 
“non-druggable” targets, can be rapidly identified and optimized [12]. For example, 
TKM-PLK1 targeting polo-like kinase 1 (plk1) gene is used to treat patients (phase 
I/II) suffering from advanced gastrointestinal neuroendocrine tumors and 
adrenocortical carcinoma by Tekmira (www.sitestage.co/pipeline/tkm-plk1.php). 
ALN-VSP02 targeting kinesin spindle protein (KSP) and vascular endothelial 
growth factor (VEGF) for the treatment of tumors and ALN-PCS02 targeting 
proprotein convertase subtilisin/kexin type 9 (PCSK9) for hypercholesterolemia 
therapy, have shown success in clinical trials and are ready to reach the market [13]. 
Meanwhile, the strategy is equally useful in terms of stem cell 
differentiation and regenerative medicine. Ever since the discovery of stem cells, 
scientists have pondered over the same question of the best way to direct stem cells 
to differentiate into desired cell types. The addition of biochemical cocktails of 
inductive factors is most commonly implemented and is a safe and convenient 
approach [14-21]. However, most of these approaches typically require an induction 
period of at least 2 weeks, hindering research progress and clinical applications 
[22]. Moreover, the bulk of these cocktails contain ligands or growth factors acting 
through cell surface receptors to induce cascades of cellular reactions that relies on 
many proteins to specify a lineage for differentiation [23]. In contrast, RNAi only 
selectively knocks down a few pivotal genes, providing a much more delicate 
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control of gene expression [22]. Many examples have shown the siRNA-mediated 
stem cell differentiation: p53 stable knockdown specifically directed embryonic 
stem cell differentiation into muscle cells under retinoic acid induction at the 
expense of a neuronal fate [24]; Stau1 knockdown directed C2C12 myoblast cells 
into a musculoskeletal lineage [25]; BCL2L2 knockdown directed human 
mesenchymal stem cells into bone cells [26]. 
B. Problems and current status of the therapeutic use 
Small-molecule pharmaceutical drugs need to adhere to the “Lipinski 
Rules” including high lipophilicity and a molecular weight less than 500. However, 
in sharp contrast, siRNAs naturally lack these drug-like properties due to their large 
size (two turns of a nucleic acid double helix), high molecular weight (over 13 kDa) 
and nearly 40 anionic charges due to the phosphodiester backbone [12]. siRNAs are 
extremely hydrophilic and heavily hydrated when their sugar-phosphate backbone 
are exposed to water. The biggest obstacle to the therapeutic use of siRNA is the 
need for in vivo delivery [27]. When administered intravenously, unmodified RNA 
can be cleaved by serum endonucleases and cause activation of innate immunity 
through the Toll-like receptor pathway [12, 13]. Both nuclease susceptibility and 
immunogenicity can be prevented by modifying the chemical structure of the 
siRNA strands, for example, replacement of the 2’ OH group of ribose with 2’-O-
methyl or 2’ fluoro groups, incorporation of locked or unlocked nucleic acids and 
substitution of phosphorothioate linkages in place of phosphodiester bonds [28-31]. 
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Another approach to shield siRNA from degradation and immune recognition is to 
encapsulate it inside nanoparticles. Delivering siRNAs selectively into diseased 
cells while sparing normal cells has been challenging. All these obstacles have 
resulted in limited enthusiasm from pharmaceutical companies for investing in 
RNAi therapeutics [13].  
In the past few years, nanotechnology researchers have developed many 
novel and efficient nanovehicles for siRNA and miRNA delivery [13]. There is a 
large growth in the usage of nanomaterials for RNAi delivery from 2009 to 2015, 
and the global delivery market grows to nearly $24 billion by 2015 at a 5 year 
compound annual growth rate of 27.9% [13]. In addition, the IC50 value for RNAi 
delivery using nanodevice systems has been reduced by 99% in only the past 5 
years [13]. These include lipidoids [32], stable nucleic acid lipid particles (SNALP), 
and ionizable cationic liquid 1,2-dilinoleyloxy-3-dimethylaminopropane 
(DLinDMA) [13]. siRNA delivered with DLinDMA, produced by Alnylam 
Pharmaceuticals, has in vivo activity at siRNA doses as low as 0.01 mg/kg in 
rodents and 0.1 mg/kg in nonhuman primates [33]. Roche’s Tekmira liposomal 
delivery technology shows unprecedented efficiency in animal challenge models for 
Ebola. More recently, Alnylam Pharmaceuticals began the development of a sugar 
molecule, ‘GalNAc’, as the targeting moiety for siRNA delivery in hepatocytes. 
Combination products enabling smart delivery of RNAi, together with existing 
potent chemotherapeutic drugs, may present the next revolution in cancer therapy 
[13]. 
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C. siRNA delivery methods 
Viral vectors have been used as an effective way for systemic delivery of 
nucleic acids in clinical trials, but they have several limitations including 
carcinogenesis, immunogenicity, broad tropism and difficulty of vector production 
[34-37]. Non-viral delivery has the potential to address many of these limitations, 
particular with respect to safety [38, 39]. However, few of these vectors have so far 
been developed clinically owing to their low delivery efficiency relative to viral 
vectors [40]. Owing to the developments in material sciences and nanotechnology, 
this drawback is about to change [41]. Many different kinds of nanomaterials have 
been designed and applied to the delivery of RNAi, including polymers, liposomes, 
hydrogels, gold nanopartilces, iron oxide nanopartilces and mesoporous silica 
nanoparticles [42]. Tumors are targeted passively, taking advantage of their leaky 
vasculature and poor lymphatic drainage as enhanced permeability and retention 
(EPR) effects, whereby the endothelial cells of the blood vessel walls possess large 
gaps between cells as compared to normal healthy tissue with tight junctions [43].  
Cellular uptake of siRNA-loaded nanoparticles most often occurs through 
endocytosis [44]. Ligands including PEG-folic acid, peptides, antibodies and sugars 
that bind specifically to receptors on target cells to trigger receptor-mediated 
endocytosis are incorporated into the delivery system to enhance the cell entry. 
The first class of nanoparticles vehicles is liposomes, which consist of a 
phospholipid bilayer wherein the amphiphilic building blocks align in a way that 
the hydrophilic heads face the interior and exterior of the supra-molecular 
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superstructure, while the hydrophobic tails form the interior of the membrane [45]. 
This dual nature gives a liposome the ability to envelop siRNAs in its interior and 
other hydrophobic molecules in its membrane. Unilamellar liposomes are 
approximately 100-200 nm in diameter, and the coating of biocompatible polymers 
like polyethylene glycol (PEG) on the surface increases the blood circulation half-
life [42]. The two types of lipid-based siRNA vectors under clinical evaluation 
include the stable nucleic acid-lipid particle (SNALP) and the lipid-based 
nanoparticles (LNPs) [33, 46, 47]. Most SNALP formulations can effectively 
deliver nucleic acids into hepatocytes, and all of the SNALP-targeted genes in 
clinical trials are disease-relevant targets in the liver [41]. LNP-based siRNA 
delivery is assessed in patients with hepatocellular carcinoma: TKM-080301 
(Tekmira Pharmaceuticals) [41]. 
Nanogels are a second class of polymer-based delivery carriers. They 
consist of hydrophilic cross-linked or self-assembled polymer networks, which have 
high loading capacities (30% wt.), good stability, and can be triggered to release a 
payload through physical expansion in response to environmental changes in pH, 
ionic strength, or temperature. Depending on the constitution of the network, and 
the degree of cross-linking, nanogels range in size form 20-200 nm. Payloads can 
be encapsulated in nanogels through different means, such as physical entrapment, 
covalent conjugation to either the interior or exterior of the nanoparticle, and 
controlled self-assembly through electrostatic or van der Walls interactions [42]. 
Cyclodextrin polymer (CDP)-based nanoparticles are the first targeted nanoparticle 
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siRNA delivery system to enter clinical trials for cancer [48]. The clinical potential 
was established in a Phase I clinical trial, in which the ribonucleotide reductase M2 
mRNA was targeted in patients with solid cancers [49]. 
Solid and hollow gold nanoparticles are another very promising vehicle for 
drug delivery. SiRNA molecules are typically tethered to the gold surface through 
Au-thiol bonds. Controlled fabrication of various sized particles (1-150 nm) with 
limited size dispersity has been established. Using ligand place-exchange reactions, 
multifunctional monolayers can be fabricated. The core is non-toxic, biocompatible, 
and inert [42]. Spherical gold nanoparticles at a size of 10 nm possess an intrinsic 
surface plasmonic absorption at ~520 nm [50], and by changing the size and shape 
of the particle like shells or rods, the absorption can be increased to the near-
infrared (NIR) region. This shift is advantageous for the purpose of photothermal 
therapy or light-stimulated targeting, because of the ability of NIR light to penetrate 
deep through tissues up to 10 cm [51, 52].  
A common problem for these non-viral delivery systems is that the cellular 
internalization via ligand-receptor interactions can be hindered by serum proteins 
absorbed on the surface of the delivery vehicle [53]. Endocytosed materials are 
entrapped in membrane-bound endocytic vesicles, which fuse with early endosomes 
and become increasingly acidic as they mature into late endosomes. For many 
delivery systems, the precise mechanism of endosomal release is poorly understood 
[41]. The exact intracellular trafficking pathways that affect delivery are so unclear. 
A recent report showed that for a leading lipid delivery system, ~70% of the siRNA 
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taken up by cells underwent endocytic recycling and expcytosis [54]. An improved 
understanding intracellular trafficking, and a better mechanism of endosomal 
release may facilitate the efficiency of delivery system [41].  
D. NIR light-controlled delivery of siRNA using hollow gold nanoshells 
Herein, we present a new platform technology based on highly 
monodisperse, hollow gold nanoshells (HGN) that can be functionalized with thiol-
linked siRNA cargo and cell penetration peptide for efficient cellular uptake [55-
57]. HGNs with ~40 nm diameter are synthesized through a galvanic replacement 
reaction of Ag seed with gold in citrate buffer. Thiolated sense strands of siRNA 
are assembled onto the citrate-passivated HGN surface using a low pH-induced 
self-assembly method, wherein negatively charged phosphate backbones are 
neutralized and the RNA assembly can be maximized. After the hybridization of the 
anti-sense strand, siRNA duplexes are loaded densely on HGNs, and are well 
protected from enzymatic attack. Cell penetration peptides including RPARPAR or 
trans-activating transcriptional activator (TAT) are then coated on top of the siRNA 
layer, through direct conjugation or streptavidin-mediated assembly for cancer cell 
targeting or generic wide-spectrum cell type penetration (Figure I-1A).  	  
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Figure I-1. Schematic of NIR light-activated siRNA delivery. (A) siRNA 
cargo attached to the HGN by thiol linkers is rapidly endocytosed (B) into 
endosomes. (C) Pulsed NIR light causes thiol bond cleavage and cargo release 
(D) Followed by nanobubble-induced endosome rupture. (E) Cargo is released 
from the endosome to cytosol. 
 
Following endocytosis (Figure I-1B), the plasmon-resonant HGN is 
activated by picosecond NIR light pulses; the light energy is converted within 
picoseconds into “hot electrons” that cleave the thiol bonds linking the HGN to the 
siRNA cargo [58] (Figure I-1C). In the following nanoseconds, the HGN dissipates 
its heat by vaporizing a minute amount of water surrounding the HGN, forming 
vapor nanobubbles that insulate both the cell and cargo from significant 
temperature changes [59-64]. The nanobubbles rapidly expand and collapse, similar 
to cavitation bubbles in ultrasound, leaving no toxic chemical residue [61, 65] 
(Figure I-1D).  Mechanical forces generated by the bubbles rupture the endosomes 
providing a unique method of endosome escape and fast, efficient and spatio-
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temporally controlled protein or siRNA delivery to the cytoplasm [59, 60] (Figure 
I-1E), overcoming the ineffective endosomal escape that plagues other nanoparticle 
methods [39, 66, 67]. 
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II. Efficient and targeted delivery of cancer-therapeutic siRNA 
A. Abstract 
We have combined a versatile and powerful route to deliver nucleic acids 
with peptide-based cell-specific targeting. siRNA targeting the polo-like kinase 
gene is in clinical trials for cancer treatment, and here we deliver this RNA 
selectively to cancer cells displaying the neuropilin-1 epitope using gold nanoshells. 
Release of the siRNA from the nanoparticles results from irradiation with a pulsed 
near-infrared laser, which also provides efficient endosomal escape within the cell. 
As a result, our approach requires ten-fold less material than standard nucleic acid 
transduction materials, and is significantly more efficient than other particle based 
methods. We also describe a particle-nucleic acid design that does not rely on 
modified RNA, thereby making the preparation of these materials more efficient 
and much less expensive. These improvements, when combined with control over 
when and where the siRNA is released, could provide a powerful means of targeted 
drug delivery. 
B. Introduction 
Here we delivered therapeutic siRNA specifically to cancer cells through the 
use of a cancer-cell specific targeting peptide. Peptides provide advantages over 
other targeting approaches (e.g., antibodies) due to their small size, synthetic 
versatility, and cell and tissue specificity [1-3]. We employed a peptide following 
the C-end rule (CendR), RPARPAR (RP) [4], that binds specifically to the 
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neuropilin-1 (NRP-1) receptor over-expressed by certain types of cancer cells. We 
targeted the polo-like kinase (PLK1) expressed by the plk1 gene in prostate cancer 
cells, critical to centrosome maturation during mitosis, to induce a pro-apoptotic 
pathway [5]. RNAi-based plk1 gene down-regulation forms the basis of Phase I/II 
clinical trials for the treatment of solid tumors [6]. 
C. Assembly and characterization of the delivery vehicle 
Figure II-1. HGN-siRNA-RPARPAR (RP) architecture with original or 
modular design and schematic of nanoparticle uptake, laser-activated siRNA 
delivery pathway in PPC-1 cells. A) TEM image of HGNs. B) Schematic of the 
original HGN-SD-RP architecture and second-generation architecture for 
modular HGN-LD-RP to achieve versatile siRNA assembly. C) Schematic of 
nanoparticle uptake and laser-activated siRNA delivery pathway. 
 
We designed a scheme for attaching peptides to the outside of a thiolated 
nucleic acid monolayer that can be expanded to include a variety of RNA cargo 
(Figure II-1A,B). Multiple copies of siRNA against plk1 were conjugated to the 
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surface of the ~50 nm HGN either directly or supported by a single strand DNA 
linker through aquasi-covalent (Au-S) bond, simultaneously maximizing drug 
content, stability, and linkers for multivalent presentation of peptides (Figure II-
1B). The siRNA and RP coated HGNs internalize into endosomes through the 
induction of Neuropiline-1 receptor mediated endocytosis (Figure II-1C). Upon 
pulsed NIR laser irradiation, the Au-S bond linking the siRNA to the HGN surface 
is ablated while the conversion of light energy to heat produces a transient vapor 
bubble that ruptures the endosome, without damaging the siRNA or the cell, 
releasing the cargo into the cytosol (Figure II-1C). This combination of steps results 
in highly efficient transfer of siRNA with specificity from the both the targeting 
peptide and the laser irradiation to ensure RNAi function occurs only in the doubly 
targeted cells (see below).	
To prepare the siRNA functionalized nanoparticles (HGN-SD-RP, Figure II-
1B) for gene knockdown, siRNA sense strands containing 5’ thiol modifications 
were assembled onto the citrate passivated HGN surface using a low pH-induced 
self-assembly method [7]. RNA strands were added to HGNs in low pH (3.0) 
sodium citrate buffer to neutralize the negatively charged phosphate backbone and 
maximize the assembly rate. Anti-sense RNA strands were then hybridized to the 
sense RNA strands to form siRNA duplexes. The residual HGN surface was then 
passivated with thiol-polyethylene glycol (PEG)-amine (3 kDa) and 6-mercapto-1-
hexanol (MCH). The RP peptide, carrying a fluorescein dye (FAM) for tracking and 
characterization as well as a cysteine for conjugation, was incorporated to the  
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Figure II-2. HGN-SD-RP synthesis and characterization. A) Schematic of 
the HGN-SD-RP synthesis steps. B) Size distribution of nanoparticles for the 
steps during coating. HGN-citrate has a Z-average diameter of 56 nm; HGN-
ssRNA 66 nm; hybridized HGN-dsRNA 73 nm; final construct HGN-dsRNA-
RP 89 nm. C) Absorption spectrum of HGN broadens and red-shifts along 
with the increase of particle size at each coating step. 
		
HGN-siRNA via short PEG linkers to bridge the amine on the 3’ sense strand and 
the thiol (cysteine) on the peptide to enable cancer cell-specific targeting (Figure II-
2). Initially the citrate HGN showed a resonance at ~710 nm, which red-shifted to 
~810 nm as the layers were assembled (Figure II-2C). This assembly method 
resulted in highly efficient loading of siRNA duplexes (~2300±600 per particle) 
(Figure II-3). 	  
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Figure II-3. Native-PAGE and densitometry analysis of chemically released 
siRNA (SD) from HGN. A) Native-PAGE gel of siRNA KCN-released from 
HGN (lanes 1-4, replicates from the same sample), and calibration siRNA 
concentration gradient (lanes 5-9). B) Calibration curve correlating known 
siRNA concentration and band intensity from densitometry measurement. 
	
 
Irradiation of the final product HGN-SD-RP with pulsed laser light (1 KHz 
repetition rate, ~120 fs pulse length) at 800 nm at a laser power density of 2.4 
W/cm2 for 10 s released ~85% of total siRNA (Figure II-4A, 100% release achieved 
by HGN dissolution using KCN). The absorbed energy caused the Au-S bonds to be 
cleaved by hot electrons and the subsequent heating of the Au lattice [8, 9]. 
Importantly, the siRNA remained hybridized and biochemically active after the 
laser release (Figure II-4B). 	  
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Figure II-4. NIR laser-dependent release of siRNA from HGN. A) Laser 
release efficiency of HGN-SD-RP with 10 s pulsed laser treatment (1.3, 2.4, 4.0 
W/cm2) compared to KCN chemical release (taken to be 100%). B) Native 
PAGE analysis of released RNA. Lanes 1 and 2 show dsRNA released with 
laser treatment at 4.0 W/cm2 for 10 s. The lack of ssRNA (23 nucleotide length) 
upon laser treatment suggests the duplex RNA remains hybridized.  
		
D. Endosomal escape of siRNA 
The down-regulation effect of plk1-siRNA released from HGNs was tested using 
the epithelial prostate cancer cell line PPC-1, which overexpresses the NRP-1 
receptor targeted by the RP peptide. Western blot and cell viability assays were 
used to assess and quantify down-regulation of plk1 (Figure II-5). Irradiation with 
the femtosecond pulsed NIR laser (2.4 W/cm2 for 10 s) of cells exposed to HGN-
SD-RP led to 70% loss of cell viability at 72 h (Figure II-5A, sample H), similar to 
the effect of unconjugated siRNA transfected using commercial Lipofectamine 
RNAiMAX(Lipo). The Lipo treatment required ~13 fold more siRNA (0.37 nM  
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Figure II-5. Functional plk1-siRNA released from HGN-SD-RP by NIR-
laser (2.4 W/cm2 for 10 s) leads to loss of PPC-1 cell viability and down-
regulation of PLK1 protein levels. A) NIR-laser treatment of PPC-1 cells 
having internalized HGN-SD-RP (H) causes a significant decrease of cell 
viability similar to the effect of lipofectamine (G). A series of controls (defined 
in the text) are shown in the table underneath the growth curve. ***: p < 
0.001; ns: not significant. B) Western blot analysis showing knockdown of plk1 
gene expression in PPC-1 cells. Red boxes highlight the down-regulated 
expression of plk1 in cells with laser-released siRNA from HGN-SD-RP. The 
column graph underneath shows the band intensity ratio of PLK1 to β-actin in 
Western blot image. 
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Figure II-6. Q modification on 5' end of anti-sense strand in PLK1-siRNA 
blocks the siRNA knockdown activity, as indicated by cell viability. A) 
Different siRNA structures with or without Q at different sites on the strands. 
B) Cell viability assay 72 h after Lipofectamine transfection of different siRNA 
options. Second generation of siRNA architecture shows similar knockdown 
efficiency as original short duplex structure. Q modification on 5' end of 
siRNA anti-sense strand blocks the siRNA knockdown activity (C, D and F). 
		
siRNA compared with 5 nM siRNA for 5000 cells) (Figure II-5A, sample G).  Like 
other nanoparticle approaches that also require considerably more siRNA, Lipo 
lacks an  efficient escape mechanism fromendosomes. Cells exposed to the same 
laser conditions in the absence of HGN-SD-RP showed no loss of viability (Figure 
II-5A, sample B). HGN-siRNA-Q-RP (where Q indicates Quasar570 dye, placed 
here on 5’ anti-sense RNA, which blocked siRNA activity against plk1, Figure II-6) 
and HGN-dsDNA25bp-RP (loaded non-functional dsDNA in place of the siRNA) 
were employed as negative controls and were also used to test whether the local 
heating caused by NIR laser irradiation in the presence of HGNs, induced cellular  
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Figure II-7. NIR laser power optimization for effective siRNA release from 
HGN surface with minimum cell damage caused by particle local heating. 
PPC-1 cells incubated with either HGN-SD-RP or HGN-dsDNA-RP are 
exposed to different laser power intensity and irradiation duration 
combinations. 
		
damage (Figure II-5A, samples E-F). The targeting peptide was necessary for the 
internalization of nanoparticles into PPC-1 cells, as laser treatment of cells exposed 
to HGN-siRNA without RP did not show any knockdown or cell death (Figure II-
5A, sample C). Figure II-5A shows that the HGN-SD-RP was the only construct to 
cause significant loss of cell viability upon laser exposure. Cells exposed to HGN-
SD-RP, but not to the NIR laser showed no effect, demonstrating that laser 
irradiation was required to activate the biological response in the cells, providing 
for both spatial and temporal control of knockdown [8]. The minimum laser 
exposure power and time for effective siRNA release in cells was 2.4 W/cm2 for 10 
s (Figure II-7). Western blot analysis confirmed the down-regulated plk1 expression 
level in PPC-1 cells treated with HGN-SD-RP and NIR laser after 48 h and 72 h.  
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Figure II-8. NIR laser-activated release of siRNA from HGN-SD-RP in 
PPC-1 cells demonstrated by confocal fluorescence microscopy and flow 
cytometry. A) Fluorescence microscopy (FAM channel) of HGN-SD-RP taken 
up by PPC-1 cells. B) The same area of the cell monolayer showed in A) after 
NIR pulsed laser irradiation efficiently releases HGN cargo. C) Difference map 
of A) and B). Scale bar is 50 µm. D) Fluorescence intensity ratios of B) to A) 
for pixels in the selected four red regions. E) PPC-1 cells were incubated with 
HGN-SD-RP then cell fluorescence intensity was assessed by flow cytometry 
before (red) and after (blue) pulsed NIR-laser treatment compared to fully 
untreated (no HGN-SD-RP, no laser) PPC-1 (black). Bars indicate the 
percentage of cells with the fluorescence signal above the brightest 1% of the 
unlabeled control cells. 
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We observed a ~60-70% decrease of the PLK1/β-actin band intensity in Figure II-
5B, for lanes G and H, compared to untreated cells (lane A) and to cells carrying 
HGN-SD-RP, but not irradiated by the laser (lane D). This result likely 
underestimated the knockdown, as only live cells were used for the Western 
analysis. 
FAM-labeled HGN-SD-RP was readily internalized into PPC-1 cells (Figure 
II-8A). The siRNA release was assessed using both fluorescence confocal 
microscopy and flow cytometry. The FAM label on the HGN-SD-RP is ~50% 
quenched at distances of ~10 nm or less from the gold; when the SD-RP is released 
by the laser, the fluorescence roughly doubles in intensity [10]. Femtosecond pulsed 
laser irradiation caused both a significant increase and expansion of FAM 
fluorescence (from individual puncta to more uniform, diffuse) in the cytosol of 
each cell, indicative of the release of siRNA-RP in individual cells as shown by 
confocal microscopy (Figure II-8A-C). Regions of interest were selected, enclosing 
either single cells (Regions 2, 3, and 4 in Figure II-8A-B) or the glass slide 
background (Region Blank 1) to conduct pixel intensity analysis (Figure II-8D). 40-
60% of the pixels in cells showed greater than 1-fold increase in intensity, whereas 
almost 100% of the pixels in the Blank 1 region showed no fluorescence increase 
(Ratio ~1) following laser treatment. Flow cytometry showed an increase in average 
intensity (Figure II-8E). We noted that ~30% of the PPC-1 cell population after 
HGN-SD-RP internalization showed a significant fluorescence signal, defined by 
being above the brightest 1% of the unlabeled control cells. The percentage 
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increased to ~70% after laser irradiation (Figure II-8E), due to a 2.5-fold increase in 
mean cell intensity that was consistent with maximal release of the SD-RP from the 
HGN. This also suggests that at least 70% of the cells efficiently internalized HGN-
SD-RP. 
Figure II-9. HGN-siRNA-RP dosage titration for effective siRNA 
knockdown in PPC-1 cells. Various concentrations of HGN-siRNA-RP were 
incubated with PPC-1 cells, treated with laser, and then plated to 96-well plate 
to assay cell viability after 72 h. 
		
The minimum HGN-SD-RP dosage used for efficient siRNA knockdown 
and cell death (Figure II-9) was 6.5 pM nanoparticles carrying 15 nM siRNA for 
2×105 cells (~4000 nanoparticles per cell). The reported concentration represented 
the amount of HGN-SD-RP available per cell;	 the amount internalized was likely 
lower. Even so, the concentration was orders of magnitude less than other 
nanoparticle approaches that required 106-107 nanoparticles or more per cell to get 
effective knockdown of the respective genes [11-13]. Meanwhile, the plk1-siRNA 
dosage needed for maximum cell viability loss by this method was ~10 times less 
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than other reported plk1-siRNA delivery methods [5, 14-18]. Lower particle and 
siRNA concentrations likely resulted from the combination of efficient particle 
internalization due to peptide targeting and endocytosis, and efficient siRNA escape 
from the endosomes via vapor bubble formation and endosome rupture.				
E. Prostate cancer cell-specific targeting 
Figure II-10. Targeted delivery of HGN-SD-RP. A) HGN-SD-RP are 
internalized into PPC-1 cells but not in RWPE-1. Upper right inset: bright 
field; scale bars: 50 µm. B) Flow cytometry assessment of PPC-1 and RWPE-1 
cells fluorescence. C) siRNA delivered to RWPE-1 cells by Lipo induces 
decreased viability, indicating susceptibility to plk1 knockdown. 
 
Normal human prostate epithelial RWPE-1 cells lack the NRP-1 receptor on 
the cell surface, resulting in negligible HGN-SD-RP internalization (Figure II-10A). 
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By flow cytometry only ~1% RWPE-1 cells were above threshold fluorescence 
intensity, compared to 30% of PPC-1, which express NRP-1 (Figure II-10B). As 
expected, there was no down-regulation of plk1 or loss of cell viability on laser 
treatment of RWPE-1 cells (Figure II-10C). However, RWPE-1 cells were sensitive 
to plk1-siRNA, as shown using the non-selective Lipo transfection of the siRNA 
construct. 
F. Modular RNA assembly 
The HGN-SD-RP (Figure II-1B) relies on a thiolated RNA to attach to the 
SD-RP to the HGN, similar to other nanoparticle-based approaches [8],[11-13]. 
After validating the release efficiency, the targeting peptide specificity, and the 
siRNA function in knocking down plk1 expression, we created a new tethering 
molecule that could integrate all the above functionalities into a versatile modular 
architecture with greater flexibility toward delivering a generic siRNA cargo 
(HGN-LD-RP, Figure II-1B), with the possibility of other peptide targeting 
sequences. Our goal was to develop a universal HGN-DNA assembly requiring 
only the addition of non-modified (less expensive and more readily available) RNA. 
An anchoring thiol-DNA-amine strand was assembled on the HGN and later 
conjugated to the targeting peptide, as a replacement for the anchoring by thiol-
RNA-amine. This core module was hybridized to a siRNA precursor designed with 
an overhang on its anti-sense strand complimentary to the anchor sequence 
(OHRNA) (Figure II-1B). We tested a variety of siRNA orientations and dye labels 
and positions keeping a constant OHRNA sequence (Figure II-6A, structures E-G).  
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Figure II-11. Comparison of siRNA coating density between SD and LD on 
HGN. A) Fluorescence intensity of KCN-released SD siRNA was measured and 
the contribution per HGN calculated. B) Native-PAGE of KCN-released 
siRNA from HGN. Lane 1: KCN-released SD; lane 2: KCN-released LD. 
 
We compared the gene knockdown activity of the various combinations to 
conventional lipofectamine transfections. The 50 bp DNA-RNA ‘long’ duplex (LD) 
was nearly as effective as the short siRNA (Figure II-6B). Fluorescence-based 
quantification after KCN release of HGN-LD-RP showed that the number of larger 
LD strands per particle was ~60% of the number of the smaller HGN-SD-RP 
strands (Figure II-11). The down-regulation activity of the HGN-LD-RP was 
assessed on PPC-1 cells as with the HGN-SD-RP siRNA system. The down-
regulation activity of the HGN-LD-RP was assessed on PPC-1 cells as with the 
HGN-SD-RP siRNA system. Cell exposure to the laser at 2.4 W/cm2 for 10 s 
resulted in 46% reduction of cell viability at 72 h, in comparison with 70% from the 
HGN-SD-RP, and from the same LD construct transfected by Lipo (Figure II-12B). 
Cell uptake efficiency and cargo release were also evaluated by flow cytometry. 
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Approximately 19% of the PPC-1 cells incubated with HGN-LD-RP show 
fluorescence intensity above threshold before laser irradiation. The percentage 
increased to ∼34% after laser treatment (Figure II-12A). This suggests that although 
the LD construct retains the cell targeting ability, improvements may be necessary 
to increase the efficiency of cell uptake by modifying the peptide conjugation 
strategy, optimizing the overhang sequence, or tuning the hybridization conditions 
to increase the cargo density. 
Figure II-12. Cell uptake and knockdown efficiency assessment of the 
nanocarrier with new modular design (HGN-LD-RP). A) HGN-LD-RP 
internalization detected by flow cytometry analysis of PPC-1 cells after 
incubation with HGN-LD-RP and laser treatment. B) PPC-1 cell viability 
assay 72 h after laser treatment (2.4 W/cm2 for 10 s) indicates siRNA release 
and RNAi from modular HGN-LD-RP. 
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G. Summary 
We have successfully developed two modular plasmonic siRNA 
nanocarriers coupled to hollow gold nanoshells for RNAi-mediated gene 
knockdown. The construct is engineered to specifically target cancer cells using the 
RPARPAR ligand against over-expressed NRP-1 receptor on the PPC-1 prostate 
cancer cell surface to promote cell internalization via endocytosis. The siRNA is 
released from the HGN and the endosome by femtosecond pulses of near infrared 
light at 800 nm; the light energy is converted into heat, which thermalizes the thiol 
bonds holding the siRNA to the HGN, followed by vapor bubble formation that 
ruptures the endosomes, without damaging the siRNA or the cell. This combination 
can provide cargo delivery with cellular level resolution at the desired time [8], with 
ten times less siRNA than techniques with comparable transfection efficiency. Our 
results show minimum off-target toxicity as evidenced by the lack of cell viability 
changes with RWPE-1, which does not express NRP-1. Control of laser irradiation 
provides an additional targeting effect, as PPC-1 cells were also unaffected in the 
absence of laser treatment. Our approach shows high selectivity and RNAi delivery 
with high efficiency, versatility and reduced cost. In particular, the modular design 
we introduce here provides a basis for future applications requiring only the 
annealing of unmodified siRNA precursor to previously prepared and generic 
HGN-DNA carriers. The combination of NIR laser-based release and endosomal 
escape, targeting peptide induced cell-specific internalization, and a versatile 
siRNA loading strategy substantially improves on our ability to use nanoparticles to 
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target RNAi to specific cell types and even individual cells and furthers the 
possibility of using modular constructs for RNAi screening assays and for in vivo 
cancer therapy. 
H. Materials and methods 
1. Hollow gold nanoshell synthesis 
Hollow gold nanoshells were synthesized as described previously. Silver 
seed particles were prepared by reducing a stirred solution of 500 mL of 0.2 mM 
AgNO3 with 0.5 mL of 1.0 M NaBH4 in the presence of 0.5 mM sodium citrate in 
deionized water. The solution was stirred for two hours at 60°C to allow NaBH4 to 
fully hydrolyze. Larger silver nanoparticles to be used as sacrificial templates for 
HGN were grown from the silver seed solution by adding 0.75 mL of 2 M NH2OH 
HCl and 1.75 mL of 0.1 M AgNO3 and stirring overnight. The galvanic replacement 
of the silver template particles with gold was optimized to have an absorbance peak 
at around 800 nm by quickly mixing 3.2 mL of 25 mM HAuCl4 at 60°C. The 
solution was cooled to room temperature (RT) and kept in dark for at least several 
days to allow the excess Ag+ that formed AgCl to settle to the bottom. HGN was 
then placed in a 3500 MWCO Slide-A-Lyzer (Thermo) in 3500 mL of 500 µM 
citrate buffer at pH 5.5. 0.1% of diethylpyrocarbonate (DEPC, Sigma) was added to 
neutralize any RNase activity, and stirring for 2 days at RT allows the DEPC to 
decompose. TEM imaging was performed using a FEI Tecnai G2 Sphera 
microscope (200 kV). Size distribution analysis was done by dynamic light 
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scattering (DLS) with a Malvern Nano ZS with autotitrator instrument. Optical 
characterization was performed by UV-VIS spectrophotometry with a UV-1700, 
PharmaSpec instrument. Particle concentration was estimated using the 
nanoparticle-tracking analysis system Nanosight LM10HS (Nanosight, Amesbury, 
UK).	
2. HGNs concentration determination 
Particle concentration was estimated using the nanoparticle-tracking 
analysis system Nanosight LM10HS (Nanosight, Amesbury, UK), equipped with a 
sample chamber NanoSight LM14 with a 638 nm laser and a Viton Fluoroelastomer 
O-ring. The samples are injected in the sample chamber at room temperature with 
sterile syringes (Kendall Monoject, Mansfield, MA) until the liquid reached the tip 
of the nozzle. The software used for capturing and analyzing the data is the NTA 
2.3 Build 0025. The samples are measured for 60 s with manual camera level 
adjustments. The Nanosight system shows excellent accuracy by calibrating with 
monodisperse 50 nm and 60 nm diameter solid gold nanoparticles with known 
concentrations (Ted Pella Inc, CA). HGN with maximum absorption at 2.0 optical 
density (1.0 cm path length) was determined by Nanosight to contain 3.9×109 
particles per milliliter. A linear correlation is observed when measuring the 
maximum absorption of HGN with a serial of dilutions, suggesting that HGN 
follows the Beer-Lambert Law. Particle concentration was estimated to have an 
extinction coefficient of 3.1×1010 M-1 cm-1 at the NIR plasmon peak maximum 
absorbance.	
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3. Thiolated DNA or RNA preparation and assembly on HGNs 
Modified sense RNA strand RNA-1, control DNA strand DNA-1 and 
anchoring DNA strand for modular design DNA-4 (Table II-1) were purchased 
from Biosearch Technologies. The RNA strand was dissolved in water (RNase-
free) to a concentration of 100 µM and aliquoted at 200 µL volume per tube (1.5 
mL RNase-free Eppendorf) followed by vacuum evaporation. The dried RNA was 
treated with 100 µL of 100% ethanol and stored at -80oC. On thawing, RNA 
disulfide protection was removed by first vacuum-evaporating the ethanol and then 
adding 200 µL of water and 5 µL Tris(2-carboxyethyl)phosphine HCl at pH 7.0 
(TCEP, 0.5 M, #646547-10 X 1mL, Sigma). After 10 min, CHCl3 (800 µL) was 
mixed to extract and remove the mercaptohexanol, carefully discarding the organic 
phase, and repeating for a total of four extractions. The aqueous layer was 
transferred to a new tube and used immediately. 
Freshly prepared thiol- sense RNA or DNA strands were assembled onto the 
HGN using a fast pH-induced self-assembly method. ~0.1 nM HGN were combined 
with 9 µM freshly reduced thiol-modified DNA or RNA (100 µM in 12.5 mM 
TCEP pH7.0) and 10 mM sodium citrate-HCl (Na3Cit-HCl, 500 mM, pH 3.0, 
RNase free), sonicated, and incubated at RT for 20 minutes. Thereafter the solution 
was pH-neutralized by adding 130 mM HEPES buffer (1 M, RNase free, pH 7.5, 
Ambion), then salted to 1 M Na+ in steps, using 3.0 M NaCl, 0.3 M Na3Cit pH 7.0 
(20X SSC, RNase free, Promega), in ~300 mM Na+ increase per step, waiting 5 
minutes between each step. 1 mM MgCl2 (1 M, RNase free, TEKNOVA) and 
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0.01% Tween-20 (RNase free, Promega) were added and incubated overnight at RT 
to increase DNA or RNA density on the HGN. The next day HGN-Anchoring DNA 
or RNA were washed by centrifuging twice at ∼7000×g for 10 min, each time 
keeping the pellet and redispersing with washing buffer (1 mM MgCl2, 0.01% 
Tween-20, 300 mM NaCl, 30 mM Na3Cit pH 7.0).	
4. DNA or RNA hybridization on HGNs  
Anti-sense strand RNA-2 or RNA-4 (all RNA, Biosearch) (Table II-1), 
complementary DNA strands for control DNA-2 (all DNA, Biosearch) or 
complementary RNA strands for modular design RNA-3 and RNA-5 (all RNA, 
Biosearch) were added at 3 µM to a washed stock of 1 mL HGN-anchoring DNA or 
RNA (0.1 nM) and incubated at 70˚C for 2 minutes followed by 45˚C for 30 
minutes. Excess DNA or RNA was removed with conjugation washing buffer (100 
mM HEPES pH 7.5, 1mM MgCl2, 0.01% Tween-20). Thiol-PEG-amine (3 kDa, 
Rapp Polymere GmbH) in ethanol was added at 100 µM to backfill any large 
exposed surface sites. After 1 h, excess thiol-PEG-amine was removed by 
centrifugation at ~7000×g for 10 minutes and pellet was resuspended in conjugation 
wash buffer. 6-mercapto-1-hexanol (MCH, Sigma) in ethanol was added at 5 µM to 
further passivate HGN surface sites. After 3 h, HGN-dsDNA or HGN-siRNA were 
centrifuged (at ~7000×g for 10 minutes) and washed with conjugation wash buffer 
to remove excess MCH.	
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5. RPARPAR peptide conjugation  
A large excess (~1 mg/mL) of MAL-dPEG4-NHS linker (Quanta Biodesign, 
CAS# 756525-99-2) for conjugation of the HGN-dsDNA or siRNA and the 
targeting peptide was added to functionalize the 3’ end of anchoring the DNA or 
RNA. The solution was sonicated briefly and incubated for 15 minutes at RT, 
followed by centrifugation at ~7000×g for 10 minutes at 4˚C and pellet 
resuspension with conjugation wash buffer twice to remove excess linker. 20 µM of 
FAM-Cys-X-RPARPAR-OH peptide (RP) (LifeTein LLC, X is aminohexanoic 
linker, FAM is fluorescein attached to the N-terminus, C-terminus is free carboxyl) 
was then added, the solution was briefly sonicated and incubated at RT for 1 h. The 
dsDNA or siRNA-RP coated HGN were centrifuged twice at ∼7000×g, the pellet 
redispersed in conjugation wash buffer to remove any unreacted peptide, and 
sterile-filtered through a 0.22 µm syringe filter (Millpore). The solution was then 
concentrated ~5 fold (10 nM HGN) by centrifugation at ~7000×g for 10 minutes 
with resuspension of the pellet in conjugation wash buffer. Product was stored at 
4˚C before adding to cells.	
6. Cell culture 
The human prostate cancer cells (PPC-1) were a generous gift from Erkki 
Ruoslahti (Sanford-Burnham Medical Research Institute, La Jolla, San Diego, CA). 
They were grown in DMEM/high glucose medium with phenol red (Hyclone), 
supplemented with 10% FBS (Hyclone). Noncancerous prostate epithelial cells 
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(RWPE-1) (ATCC) were grown in keratinocyte serum free medium (Invitrogen) 
supplemented with bovine pituitary extract (0.05 ng/mL) and recombinant EGF (5 
ng/mL). Both cell lines were maintained at 37 oC in 5% CO2 atmosphere and grown 
in 6-well or 96-well plates (BD Falcon) for experiments.	
7. siRNA transfection using Lipofectamine RNAiMAX 
For the typical control transfection experiment with non-HGN conjugated 
siRNA duplex, cells were plated in 96-well plates at a concentration of 3000 cells 
per well. The following day the reagents were prepared for transfection according 
to the manufacturer’s protocol, with the following quantities intended per well in a 
96-well plate format: 0.1 µL of Lipofectamine RNAiMAX and 0.1 µL of 5 µM 
siRNA were each diluted in 10 µL of OPTI-MEM reduced serum medium 
(Invitrogen), then combined and incubated at RT for 15 minutes. The transfection 
mix was then added to the wells containing the plated cells and complete growth 
medium. The following day the medium was replaced and cells imaged, scored for 
viability or allowed to grow up to 48 h or 72 h after transfection.	
8. HGN transfection and femtosecond laser irradiation 
Cells were plated in 6-well plates (24 hours before experiment) and 
harvested by incubation with 500 µL of non-enzymatic cell dissociation buffer 
(CDB, Invitrogen) at 37˚C in 5% CO2 atmosphere for 10-15 minutes, after one 
wash in calcium and magnesium free Dulbecco’s phosphate buffered saline (D-
PBS, Invitrogen). Complete growth medium was added and cells centrifuged at 
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1000×g to remove the CDB. The cell pellet was diluted in the appropriate amount 
of medium to obtain a concentration of 1×106 cells/mL. 6.5 pM of coated HGN 
were added to 200 µL of cell suspension and incubated in 1.5 mL Eppendorf tubes 
at room temperature (RT) for 2h on a rotator. 1.2 mL of cold Hank’s balanced 
saline solution (HBSS, with Ca2+ and Mg2+, pH 6.7-7.8, Invitrogen) was added and 
the tube was centrifuged at 55×g for 8 minutes at 4˚C. The supernatant containing 
free particles was removed and 45 µL HBSS were added and mixed with the cell 
pellet. Tubes were irradiated with 2.4 W/cm2 pulsed NIR laser for 10 s by the 
output of femtosecond (fs) Ti:sapphire regenerative amplifier (Spectraphysics 
Spitfire) running with 1 KHz repetition rate. The laser beam with ~4 mm diameter 
was directed onto the sample by a system of mirrors without any focusing optics. 
The pulsed duration was monitored by a home-built single-shot optical 
autocorrelator and was kept at about 130 fs. The spectral range of laser irradiation 
was ~12 nm centered around 800 nm, and the energy of the optical pulse was 
controlled by Schott neutral density glass filters. A thermopile power meter 
(Newport Inc., Irvine, CA) was used to measure the incident optical power. Cells 
were then either collected for fluorescence intensity measurement by flow 
cytometry, or plated in 96-well plates for cell viability assay and in 6-well plates for 
Western blot.	
9. Cell fluorescence intensity measurements 
Cells with internalized particles in HBSS buffer with or without 
femtosecond laser treatment were collected and injected into a BD Accuri C6 flow 
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cytometer with a flow rate of 14 µL/min. The gate was based on the lineage area of 
forward and side scatter plots, and 10,000 events were collected for each sample. 
The increase in fluorescence intensity after particle internalization or laser treatment 
was assessed by the population of the cells having intensity higher than 99% of the 
control cells.	
10. Confocal microscope imaging 
Cells were plated on a 8-well chamber glass slide (Lab-Tek II), and 
incubated with 6.5 pM coated HGN at 37˚C in 5% CO2 atmosphere for 2 h followed 
by two washes with HBSS to remove any excess HGN. An Olympus Fluoview 
1000 MPE Microscope with a 25x water immersion objective (NA 1.05) was used 
for live cell imaging. The microscope is equipped with a mode-locked titanium-
sapphire femtosecond tunable pulsed laser (MaiTai HP, Newport-Spectra Physics), 
that was used to irradiate the sample to induce cargo release from the HGN, a 473 
nm blue laser diode, used to image the FAM signal from the peptide, and a 559 nm 
green laser diode and a 633 nm HeNe laser that were not used. Images were 
collected at 12 bit with 512 X 512 pixels. The MaiTai laser was tuned to 800 nm 
and used to irradiate the sample area with a scan speed of 125 KHz for up to 35 
repetitions. The specimen was imaged in a single-photon confocal mode with the 
blue laser diode at a scan speed of 80k Hz before and after the exposure to the 
MaiTai fs laser to compare the cell fluorescence intensity difference caused by the 
laser treatment.	
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11. Cell viability assay of prostate cancer cells 
The PrestoBlue (Invitrogen) assay was used to determine the effect of 
transfection on cell proliferation for both laser treatment and controls with 
Lipofectamine RNAiMAX. For laser experiments, cells, with or without particles 
and treated or untreated with the laser, were plated in 96-well plates at a density of 
5000 cells per well. 100 µL of complete medium were added per well and cells 
were incubated for 0 h, 24 h, 48 h and 72 h, before determining cell viability. For 
Lipofectamine control experiments cells were tested for viability 24 h, 48 h, or 72 h 
after transfection. The PrestoBlue assay was used according to the manufacturer’s 
instructions: 10 µL of reagent were added to cells with 90 µL of fresh complete 
medium; the plate was incubated at 37˚C, 5% CO2 atmosphere for 2 h; the 
fluorescence signal was recorded in a Tecan Infinite 200 Pro reader in bottom-read 
mode. Excitation and emission wavelengths were set at 560 nm (9 nm bandwidth) 
and 600 nm (20 nm bandwidth) respectively. 4 replicates for each treatment were 
averaged and analyzed based on a calibration curve to determine then number of 
cells in each sample. All treatments were repeated at least 3 times and reported as 
mean ± standard deviation (SD). One-way ANOVA analysis was performed to 
determine the statistical significance of changes in cell viability for each treatment; 
p<0.001 was considered statistically significant.	
12. Western blot 
Cells, with or without particles and treated or untreated with laser, were 
plated in 6-well plates with 2 × 105 cells per well in 2 mL medium and cultured for 
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48 h and 72 h. Cells were harvested with trypsin/EDTA (0.25%, Sigma) and about 
1×106 cells were lysed in 100 µL of RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 
1% Triton, 0.5% deoxycholate, and 2 mM EDTA) supplemented with protease 
inhibitor cocktail (Promega) on ice for 30 minutes. The cell lysate was centrifuged 
at ∼12400×g, at 4˚C for 20 minutes. The supernatant was collected and combined 
with loading buffer (6X, 300 mM Tris-HCl, 0.01% w/v bromophenol blue, 15% v/v 
glycerol, 6% w/v SDS and 1% v/v beta-mercaptoethanol) and kept at 95˚C for 10 
minutes. 40 µL of this solution and 10 µL of pre-stained molecular weight standard 
(BioLabs) were loaded and separated by electrophoresis through Precast 10% SDS-
PAGE gel (Bio-rad). Proteins were electro-transferred onto a nitrocellulose 
membrane (Bio-rad). The membrane was blocked with 5% bovine serum albumin 
(BSA, Sigma) in PBST (PBS, Fisher; 0.1% Tween-20) at RT for 30 minutes, then 
incubated overnight at 4˚C with primary antibodies diluted in 5% BSA-PBST 
buffer: mouse anti-PLK1 (monoclonal, 1:500 dilution, EMD) and rabbit anti-β-actin 
(monoclonal, 1:1000 dilution, Abcam). The membrane was subsequently washed 
thrice for 15 minutes using PBST and then incubated for 3 h in 5% BSA-PBST with 
secondary antibodies including Alexa Fluor 488 labeled goat anti-mouse IgG 
(1:10,000 dilution, Invitrogen) and Alexa Fluor 647 labeled goat anti-rabbit IgG 
(1:10,000 dilution, Invitrogen), followed by wash thrice for 15 minutes using 
PBST. Images were acquired using a GE Healthcare Typhoon 9400 scanner system 
and the bands were analyzed using the scanner control software.		
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I. Appendix 
Table II-1. Oligonucleotides attached on HGNs. 
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III. Light-activated RNAi in human embryonic stem cells 
A. Abstract 
We describe a NIR light-activated gene silencing method in undifferentiated 
human embryonic stem cell (hESC) using HGN as the siRNA carrier. Our modular 
biotin-streptavidin coupling strategy enables positively charged TAT-peptide to 
coat oligonucleotides-saturated nanoparticles as a stable colloid formation. TAT-
peptide coated nanoparticles with dense siRNA loading show efficient penetration 
into a wide variety of hESC cell lines. The siRNA is freed from the nanoparticles 
and delivered to the cytosol by femtosecond pulses of NIR light with potentially 
exquisite spatial and temporal control. The effectiveness of this approach is shown 
by targeting GFP and Oct4 genes in undifferentiated hESC (H9). The accelerated 
expression of differentiation markers for all three germ layers resulting from Oct4 
knockdown confirms that this method has no detectable adverse effects that limit 
the range of differentiation. This biocompatible and NIR laser-activated patterning 
method makes possible single cell resolution of siRNA delivery for diverse studies 
in stem cell biology, tissue engineering and regenerative medicine.  
B. Introduction 
The capability of human embryonic stem cells (hESC) differentiation into 
all types of cells in the body holds immense promise in tissue engineering and 
regenerative medicine [1-3], and is of interest for generating disease models for 
drug screening. RNA interference (RNAi) has been a powerful tool to dissect 
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genetic pathways and manipulate cellular phenotypes [4-9]. However, the routine 
use of RNAi in stem cells requires efficient and biocompatible delivery methods 
[10-12], and while the commonly used viral-based RNAi methods are efficient [13, 
14], these can be time-consuming and pose substantial biosafety problems, such as 
risk of secondary infection and immunogenic response [15-17]. Commercially 
available transfection reagents such as Lipofectamine have had some success in 
hESC transfection [9, 18, 19]. However, lipofectamine use could result in 
unacceptable levels of cytotoxicity and nonspecific changes in gene expression [11, 
19-21].  
Alternative chemical transient transfection methods using nanocarriers of 
cationic lipids, polymers, and functionalized gold nanoparticles have also had 
variable success with hESC derivatives including embryoid bodies, human 
mesenchymal stem cells and neural stem cells [8, 10, 11, 22-27], but transfection of 
undifferentiated hESC remains a challenge for synthetic vectors. Importantly, 
specific targeting within populations of similar cells is not possible using current 
methods.  
To address these needs, we have developed an efficient, biocompatible and 
broadly applicable method to introduce siRNA into hESC by near infrared light-
controlled endosome rupture. This delivery method provides i) efficient endosome 
escape, ii) control over the timing of siRNA delivery to the cytosol, iii) individual 
cell-level resolution, and iv) minimal toxicity. Applications include self-renewal 
studies of undifferentiated stem cells and tissue engineering – an area with pressing 
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need for new technologies for efficient and cell-specific RNAi delivery [28, 29]. 
For example, this light-responsive RNAi release strategy has the ability to load 
different types of RNAi on the nanocarriers with distinct absorption spectrum [30] 
and activate specific RNAi in required regions of cells by corresponding light 
irradiation, which can cause the directed differentiation of stem cells to different 
cell types in a spatially organized pattern during early embryogenesis such as optic 
cup formation for ocular development [31, 32], Rathke’s pouch formation for 
pituitary tissue development [33] and tooth-germ structure for tooth growth [34]. 
To create the light-activated hESC silencing system, siRNA molecules were 
first densely assembled onto plasmonic hollow gold nanoshells (HGN) via thiol 
bond formation, then were overcoated with a protective protein layer with handles 
for attaching cell penetrating peptides [35, 36]. Upon irradiation with biocompatible 
near infrared (NIR) light (~800 nm), the siRNAs are released from the gold surface 
and endosomes [37]. In this work, we explored the ability of HIV-derived cell 
penetrating peptide (CPP) TAT (YGRKKRRQRRR) to facilitate the internalization 
of the HGNs into hESC. However, direct conjugation of TAT-peptide and siRNA-
conjugated HGNs resulted in aggregation, presumably due to colloidal surface 
charge neutralization and bridging between the cationic TAT and the anionic 
siRNA [38, 39]. We devised an alternative surface coating strategy by positioning 
TAT on the siRNA via coupling with the tetravalent protein streptavidin, which 
sterically prevents the siRNA from electrostatic contacts and thus inhibits particle 
aggregation. The resulting construct was capable of releasing siRNA payloads upon 
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NIR laser irradiation and could efficiently internalize into a variety of hESC cell 
lines.  
We optimized the knockdown and viability of hESC through a series of 
protocol variations including cellular dissociation, NIR laser intensity modulation, 
and ROCK inhibition. To demonstrate the general feasibility of this approach and 
light-dependent knockdown control, we silenced GFP in engineered H9 cells, and 
Oct4 in the original H9 cells. Based on the work described here and our prior work, 
we anticipate spatio-temporal control with siRNA to provide a powerful new 
avenue for basic research in stem cells and tissue engineering. 
C. Construction and characterization of TAT-peptide coated HGN-
siRNA 
Efficient delivery of siRNA to hESC is known to be difficult for synthetic 
vectors [19]. To overcome this limitation, we designed a multi-functional 
nanoparticle carrier by attaching the generic cell penetrating peptide TAT (biotin-
YGRKKRRQRRR) onto hollow gold nanoshells (HGNs) functionalized with 
multivalent siRNA (Figure III-1A). Multiple copies of functional siRNA molecules 
were conjugated to the surface of the ~50 nm diameter HGN through a quasi-
covalent Au-S bond, whereas uptake of the construct by hESC was mediated by the 
TAT-peptide coating on the particle surface. Upon pulsed NIR laser irradiation, the 
HGNs strongly absorb pulsed NIR laser light, which is rapidly (nanosecond) 
converted to heat, ablating the Au-S bond holding the siRNA on HGN surface and  
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Figure III-1. Nanoparticle architecture and characterization of siRNA on 
HGN, and schematic of RNAi-mediated differentiation in hESC. A) Schematic 
of the HGN-siRNA-TAT architecture, NIR laser-activated siRNA delivery and 
RNAi-mediated differentiation in hESC. Q: Quasar570. B) Size distribution 
and absorption spectra of nanoparticles during the coating steps. Upper right 
of the left panel: TEM image of the final construct. Scale bar: 50 nm. 
		
producing transientvapor bubbles that ruptures the endosome without damaging the 
siRNA [36] or the hESC (Figure III-1A). This strategy results in the successful 
intracellular transfer of negatively charged siRNA to the cytosol of hESC, thereby 
initiating RNAi-mediated gene knockdown and stem cell differentiation. 
A high number of siRNA duplexes were conjugated to the surface of each 
HGN through low pH-induced self-assembly of thiolated RNA sense strand 
followed by the hybridization of the anti-sense strand as described previously [36]. 
In our prior work (siRNA delivery to a mouse endothelial cell line), we modified 
TAT peptide with a lipid to form a lipid bilayer around the HGN-siRNA, insulating 
against nanoparticle-nanoparticle electrostatic coupling [35]. Adopting that strategy 
here generated TAT-coated HGN in a stable colloidal formulation (with an  
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Figure III-2. Characterization of HGN-siRNA coated with TAT peptide 
using different strategies. A) Absorption spectra of TAT peptide-coated HGN-
siRNA. Particles form a stable colloidal solution with all three methods of 
coating: lipid-TAT to form a lipid bilayer blocker (Lipid); siRNA backfilling 
on thiol-PEG5k-TAT pre-conjugated HGN (PEG); and streptavidin-biotin 
based insulator (STV). B) Total loading capacity and pulsed NIR laser (2.4 
W/cm2 for 15 s) releasable population of siRNA on HGN for the different 
coating strategies. 
		
absorption peak at ~800 nm) and efficient siRNA loading (Figure III-2), however, 
their internalization in hESC was not sufficient to cause effective gene silencing 
upon laser treatment (Figure III-3). Due to the synthetic constraints this strategy 
was not amenable to testing peptide sequences or other structural variations. We 
then pursued an assembly strategy wherein the thiolated siRNA molecules were 
backfilled onto thiol-PEG5k-TAT coated HGN. The nanoparticles did not aggregate 
after siRNA backfilling (Figure III-2A), and had strong internalization into hESC 
(Figure III-3A), but this approach showed inefficient laser knockdown of GFP in  
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Figure III-3. Comparison of internalization and pulsed laser-induced GFP 
knockdown in H9-GFP cells between particles from different coating 
strategies. A) Flow cytometry quantification of particle internalization in H9-
GFP cells. Particle internalization is underestimated due to optical limitations 
of the flow cytometer; however, greater histogram shift indicates that PEG and 
STV coating strategies have better penetration efficiency than that of the lipid-
based strategy. B) Mean fluorescence intensity of cells with nanoparticle (with 
GFP-siRNA and TAT peptide coating) and laser treatment. Cells are assayed 
by flow cytometry 3 days after laser treatment. 
		
cells, possibly due to the insufficient amount of siRNA release by laser (Figure III-
2B, Figure III-3B).  
Our optimized design places a ~5 nm streptavidin bridging element between 
a biotinylated RNA layer and a biotinylated TAT-peptide (Figure III-1A). The 
average hydrodynamic diameter of the final construct HGN-siRNA-Biotin-STV-
TAT (HRT) increased from 56 for bare HGN (citrate stabilized) to 151 nm (Figure 
III-1B), which can be attributed to the sum of RNA length, protein/peptide coating,  
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Figure III-4. Release of siRNA from HGN-siRNA-TAT with pulsed laser 
treatment at different powers (2.4 and 4.0 W/cm2 for 10, 15 or 20 s) compared 
to KCN chemical release (100%).  
		
and slight aggregation [40]. The plasmon resonance of the nanoparticles red-shifted 
from ~710 nm for bare HGN to ~880 nm after the final coating step (Figure III-1B). 
By tracing the dye label on the siRNA [36], we found that irradiation of HRT by 
our pulsed NIR laser at 800 nm wavelength caused the release of ~530 siRNA 
duplexes per particle (~23% of capacity), at a power density of 2.4 W/cm2 for 15 s 
(Figure III-4) with 1 kHz pulse repetition rate, ~120 fs pulse duration. This 
streptavidin-TAT coating strategy was sufficient to cause the desired biological 
effect. However, future optimization could improve the HGN monodispersity that 
dictates the sharpness of the absorption resonance peak, and more closely match 
nanoparticle absorption to the wavelength of the exciting laser.  
D. Protocol optimization and GFP knockdown in transduced hESC 
The compact clusters of hESC reduce accessibility to transfection; thus, 
protocols often rely on enzymatic digestion to generate single cells that leads to 
significant loss of cell viability [19]. We instead used a non-enzymatic method for  
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Figure III-5. H9-GFP cells dissociated by PBS treatment show better 
uptake efficiency of nanoparticles than those dissociated using commercial 
CDB treatment. The fluorescence intensity of cells incubated with 
nanoparticles is assayed by flow cytometry as an evaluation of particle 
internalization. 
		
the dissociation of the hESC that generated single cells and small cell aggregates 
(5-10 cells) while ensuring minimum cell damage, and membrane accessibility to 
nanoparticles. Notably, we found that a 10 minutes incubation of attached hESC 
with Ca2+ and Mg2+ free PBS (37 ˚C) followed by manual dissection was sufficient 
for cell dissociation. Cells generated by this mild treatment appeared to take up 
more nanoparticles than cells obtained using commercial non-enzymatic cell 
dissociation buffer treatment (CDB, Invitrogen) (Figure III-5). Crucially, addition 
of ROCK inhibitor within the first 24 hours after single cell seeding significantly 
increased the cell viability (Figure III-6). The optimized HGN transfection protocol 
(Figure III-7) that we developed here enables both efficient cellular uptake and 
robust cell viability.  
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Figure III-6. Addition of ROCK inhibitor after single H9 cell seeding 
significantly enhances the stem cell viability. A) ROCK inhibitor treatment 
after seeding for 24 h significantly preserves cell number. Under phase 
contrast light microscopy, cells are observed to elongate with the ROCK 
inhibitor addition and shorten back when removed. B) Crystal violet staining 
of colonies after 6 days affirms the robustness of ROCK inhibitor treatment. 
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Figure III-7. Flow chart describing the transfection protocol of hESCs with 
siRNA-carrying particles and subsequent NIR laser treatment. Warm PBS 
dissociation of H9 cells and ROCK inhibitor addition before cell seeding are 
essential to preserve stem cell viability.  
		
To demonstrate the NIR laser-dependent siRNA activation in hESC, as well 
as to optimize siRNA delivery efficiency, HGN particles carrying GFP-siRNA were 
incubated with GFP-expressing hESC (H9-GFP), followed by NIR laser irradiation. 
Nanoparticles with 6 pmol siRNA were used for 4×105 cells (~4000 nanoparticles 
per cell). A set of different laser powers was tested, and 2.4 W/cm2 for 15 s was 
found to have the maximum GFP silencing effect (Figure III-8A) and was selected 
for later studies. Fluorescence imaging of H9-GFP cells 3 days post treatment 
showed that GFP expression in cells decreased significantly only when cells 
carrying particles were irradiated with laser (Figure III-8B).  
Flow cytometry quantification of GFP fluorescence in H9-GFP cells at day 
3 showed that the mean fluorescence of the whole cell population after particle  
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Figure III-8. GFP knockdown in H9-GFP cells via HGN-mediated GFP-
siRNA delivery and NIR-laser excitation (2.4 W/cm2 for 15 s). A) Laser power 
and irradiation duration optimization for effective GFP knockdown in H9-
GFP cells. Cells are assayed by flow cytometry 3 days after laser treatment. B) 
Fluorescence imaging of H9-GFP cells 3 days after HRT (coated with GFP-
siRNA) internalization and laser treatment. C) Mean fluorescence intensity of 
cells with and without HRT and HDT (dsDNA control) and laser treatment. 
Cells are assayed by flow cytometry 3 days after laser treatment. Lipo: 
Lipofectamine RNAiMAX siRNA transfection. Data sets are analyzed by one-
way ANOVA. **, p < 0.01; ***, p < 0.001; NS, not significant. 
		
internalization and laser treatment decreased by ~60% compared to cells without 
particle and laser treatment (Figure III-8C), consistent with the decrease (~66%) of  
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Figure III-9. GFP knockdown in H9-GFP cells via HGN-mediated GFP-
siRNA delivery and NIR-laser excitation (2.4 W/cm2 for 15 s). Flow cytometry 
shows the population of high GFP expression (within the bar range) decreased 
by 66% after knockdown. 
		
the cell population with high GFP expression (Figure III-9). This down-regulation 
efficiency is similar to the best data using commercially available transfection 
reagents including Lipofectamine 2000, jetPRIME, and Lipofectamine RNAiMAX 
(with 15 pmol siRNA for 1×105 cells) (Figure III-8C and Figure III-10), but our 
method requires ~ten-fold less siRNA. The knockdown efficiency of our method 
can be further increased by optimizing particles to release more of the siRNA load 
upon laser treatment, and by modifying the laser irradiation protocol to illuminate 
the entire cell population. GFP expression remained unchanged in the controls, 
including cells incubated with GFP-siRNA-carrying HRT without laser irradiation, 
cells incubated with non-sense dsDNA-carrying HDT and with laser irradiation, 
and cells without nanoparticles or laser treatment (Figure III-8C). Collectively,  
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Figure III-10. Fluorescence microscopy imaging of H9-GFP cells 72 h after 
siRNA transfection using the commercial transfection reagents Lipofectamine 
2000 (Lipo2000), jetPRIME (JetPrime), and Lipofectamine RNAiMAX 
(LipoMAX) with siRNA concentration at 15 nM. LipoMAX shows the best 
siRNA transfection efficiency. 
 
these findings strongly suggest that down-regulation of GFP results from siRNA 
being released from HRT nanoparticles, and that NIR laser irradiation is necessary 
for such siRNA activation in the cells. 
E. HGN internalization in un-engineered hESC and cytotoxicity assay 
The HRT nanoparticle was then tested for the penetration into un-
engineered hESC with our optimized transfection protocol (Figure III-7). We 
labeled siRNA with Quasar570 to track the internalization of HRT into hESC H9 
cells over a 2 h incubation at 37 ˚C. Dark-field microscopy of cells after 
nanoparticle incubation showed orange-red puncta, due to the light scattering of 
HGN, surrounding the cell nucleus and this co-localized with the red fluorescence 
puncta from Quasar570 (Figure III-11A). Confocal fluorescence microscopy 3D  
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Figure III-11. Cellular uptake of HRT in un-engineered hESC. A) 
Microscopic visualization of particles internalized by hESC H9 cells. Left: 
Dark-field imaging of cells shows gold punctate dots (yellow), which are co-
localized with red fluorescent puncta (from Quasar570) surrounding the 
nucleus (blue, middle). Right: 3D image of a single cell by confocal 
fluorescence microscopy shows nanoparticles (red puncta from Quasar570) 
around the nucleus. B) Flow cytometry quantification of particle 
internalization and laser release in H9 cells. HRT(Lipid): HGN-siRNA-TAT 
by lipid coating strategy. Top right: mean fluorescence of each peak indicates 
the release of fluorescent payload. C) HRT is efficient (>97%) in penetrating a 
series of different hESC cell lines including H1, H7, H9 and H14. The bar is 
defined as being above the brightest 1% of the unlabeled control cells. 
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images of selected single cells confirmed the intracellular distribution of the siRNA 
(likely inside endosomes) near the nucleus (Figure III-11A). We quantified the 
cellular internalization by flow cytometry using the Quasar570 fluorescence 
intensity and the fluorescence change after pulsed NIR laser irradiation (Figure III-
11B). Approximately 97% of the H9 cell population showed significant 
fluorescence due to HRT uptake, defined as being brighter than the brightest 1% of 
the unlabeled control cells. We observed that the mean fluorescence of the cells was 
increased by 44% after laser irradiation, consistent with RNA payload release (since 
Quasar570 is partially quenched when near the gold surface [41]). Importantly, 
HRT showed similar high internalization efficiency (>97%) across a series of hESC 
cell lines including H1, H7 and H14 (Figure III-11C).  
To assess any effect from particles and laser treatment to cell viability, H9 
cells containing HRT with double-stranded RNA (non-sense to H9 cells) were 
exposed to NIR laser of different powers, and cultured on Matrigel-coated plates for 
5 days. Live cells growing on the plate were stained with crystal violet, while dead 
cells that had lost the ability to attach were washed during fresh medium exchange 
every other day [42, 43]. Figure III-12 shows that the laser irradiation with power 
and time at or below 2.4 W/cm2 for 15 s had no significant impairment on cell 
viability, compared to untreated control cells. Cell stemness was also not affected, 
judging by cell morphology 7 days after particle and laser treatment (2.4 W/cm2 for 
15 s), since it was normal for untreated cells to have large nuclei and be tightly  
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Figure III-12. Cell viability assessment of H9 cells after internalization of 
HRT (with dsRNA coating non-sense to H9 cells) and treatment with different 
laser powers. Top panel: cell colonies stained by crystal violet 5 days post laser 
treatment. 
		
Figure III-13. Morphology of H9 cells 7 days after treating with HRT (with 
dsRNA coating non-sense to H9 cells) and NIR laser (2.4 W/cm2 for 15 s). Cells 
internalized with nanoparticles with or without laser treatment show the same 
cell morphology as cell only control: cells have large nuclei and are tightly 
packed to form colonies with smooth edges. 
		
packed to form colonies with smooth edges (Figure III-13) [44]. Importantly, since 
the expression levels across a panel of stem cell biomarkers was not changed after 
laser irradiation of cells loaded with HDT, which carries a control double-strand 
DNA (non-sense to H9), we conclude that specific stemness changes can only be 
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related to the RNA activity, not the effects of the laser, gold, streptavidin, or 
peptide. 
F. Light-activated Oct4 knockdown accelerates hESC differentiation 
Inspired by the success of HGN-siRNA delivery in H9-GFP cells described 
above, we next set out to deliver siRNA to the original un-engineered H9 cells to 
down-regulate a gene with biological activity and investigate the biological 
outcomes. We chose to target the expression of the Oct4 gene, which is an essential 
transcription factor for embryonic stem cell self-renewal and pluripotency [45]. The 
down-regulation of this protein was reported to initiate and accelerate 
differentiation [45]. We first tested the siRNA knockdown of the Oct4 gene in H9 
cells using a lentiviral transfection method with the plasmid LL-OCT4-1/2 
(Addgene) (Figure III-14). The down-regulation of Oct4 expression in hESC H9 
cells by this means initiated the differentiation process in the mTeSR1 medium 
(control was only barely differentiated) (Figure III-14B) and accelerated this 
process in the differentiation medium (control was slower) (Figure III-14C). The 
cells stained positive for all three germ layer markers after extended culture in the 
differentiation medium (Figure III-14C). In parallel, we incubated H9 cells with our 
HRT construct HGN-siRNA(Oct4)-TAT and treated them with the NIR pulsed laser 
at 2.4 W/cm2 for 15 s optimized from H9-GFP knockdown experiment and cell 
viability test, followed by cell assays after 5 days culture in mTeSR1 medium to get 
enough cells (Figure III-15A). These conditions stimulated Oct4-siRNA function, 
as demonstrated by a significant decrease of OCT4 protein expression level at day 5  
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Figure III-14. Oct4 gene knockdown in hESC H9 cells by lentiviral 
transfection results in stem cell differentiation into all three germ layers after 
the knockdown in mTeSR1 medium. A) Western blot analysis showing the 
knockdown of Oct4 gene expression in H9 cells 6 days after lentiviral 
transfection. The bar graph beneath summarizes densitometric intensity ratio 
of OCT4 to β-actin. B) Flow cytometry of H9 cells immunostained with stem 
cell markers TRA-1-60 and SSEA4 11 days post lentiviral transfection in 
mTeSR1 medium. C) Immunocytochemistry of βIII-tubulin (TUBB3, ectoderm 
marker), α-smooth muscle actin (α-SMA, mesoderm marker) and α-
fetoprotein (AFP, endoderm marker) on H9 cells 22 days after lentiviral 
transfection (12 days in mTeSR1 followed by 10 days in the differentiation 
medium) showing differentiation into all three germ layers.  
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Figure III-15. Release of Oct4-siRNA from HRT in H9 hESC cells by NIR 
laser (2.4 W/cm2 for 15 s) down-regulates OCT4 protein levels and leads to 
stem cell differentiation in the mTeSR1 medium. A) Time schedule of the 
whole protocol and assays of particle and laser treatment to cells. B) ICC 
staining of H9 5 days after particle internalization and laser treatment. C) 
Flow cytometry of H9 cells stained with stem cell markers 5 days post particle 
and laser treatment in mTeSR1 medium, compared to the undifferentiated 
cells in controls (hESC only, HRT without laser and HDT with laser). D) 
Western blot analysis of OCT4 protein level in H9 cells. The bar graph 
underneath shows the band intensity ratio of OCT4 to β-actin in the Western 
blot image. E) Morphology of cells 5 days post HRT or HDT and laser 
treatment (cultured in the mTeSR1 medium). 
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confirmed by immunocytochemistry (ICC) staining and Western blot assay (Figure 
III-15B-D). Flow cytometry quantification at day 5 (cells cultured in mTeSR1 
medium) showed that ~50% of the cell population had decreased their expression of 
stem cell markers including OCT3/4 and TRA-1-60, as evidence of cell 
differentiation (Figure III-15C). Limited by cell number, our analysis of the  
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Figure III-16. H9 cell morphology in mTeSR1 medium 1, 3, 5 and 7 days 
after HRT (with Oct4-siRNA coating) and laser (2.4 W/cm2, 15s) treatment, 
relative to negative control. Differentiation morphology with expanded cytosol 
and dissociated colonies is observed on day 5.  
		
knockdown and differentiation assay carried on day 5 might be an underestimation 
of the true knockdown efficiency since we noticed that undifferentiated cells divide 
more quickly than differentiated cells in mTeSR1 medium.  
Figure III-15E and Figure III-16 show that cells cultured with HRT and 
exposed to laser treatment exhibited differentiated cell characteristics: enlarged cell 
size, increased cytoplasmic area with decreased nuclear-to-cytoplasmic ratio. 
Consistent with the GFP knockdown experiments, laser exposure of HRT was 
required for the knockdown effect. Cells treated with HDT (HGN-dsDNA-TAT 
carrying non-sense dsDNA) did not show any apparent down-regulation of OCT4 
protein, loss of stem cell markers or stem cell morphology change (Figure III-
15C,E), supporting that the particle internalization and laser treatment themselves 
have no side effects on cell stemness. Together, the results confirm that the down-
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regulation of Oct4 gene in H9 cells by this strategy leads to stem cell differentiation 
in a NIR laser-dependent manner. 
As laser-induced siRNA delivery in hESC has not been explored previously, 
we investigated whether this method might cause cell differentiation to be biased 
toward certain germ layers. Cells were siRNA-treated and then assayed from day 
20-28 by ICC staining of three germ layer biomarkers including βIII-tubulin 
(TUBB3, for ectoderm), α-smooth muscle actin (α-SMA, for mesoderm) and α-
fetoprotein (AFP, for endoderm), and reverse transcription PCR (RT-PCR) analysis 
of several biomarkers’ mRNA expression (Figure III-17A). Note that after the 
particle and laser treatment, the cells were switched to the differentiation medium to 
avoid the overwhelming growth of undifferentiated cells in mTeSR1 medium, then 
further cultured and assayed. Consistent with our observation from lentiviral Oct4 
knockdown, HGN- and laser-dependent Oct4 knockdown accelerated the 
differentiation process compared to untreated self-differentiation in differentiation 
medium, as indicated by biomarker ICC staining and RT-PCR analysis (Figure III-
17B,C). H9 cells without particle and laser treatment (but with the same culture 
protocol) showed an apparently lower expression of TUBB3 and AFP at day 28, as 
compared to cells with particle and laser treatment (Figure III-17B). RT-PCR 
analysis of biomarkers for all three germ layers confirms the delay at the mRNA 
level of untreated cells (Figure III-17C). Importantly, both ICC and RT-PCR 
analysis 
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Figure III-17. The HGN and NIR laser-mediated Oct4 gene knockdown 
accelerates the ability of hESC H9 cells to differentiate into all three germ 
layers in differentiation medium. A) Time schedule of cell differentiation test 
in differentiation medium post laser irradiation. B) ICC of βIII-tubulin 
(TUBB3, ectoderm marker), α-smooth muscle actin (α-SMA, mesoderm 
marker), and α-fetoprotein (AFP, endoderm marker) for cells 20 or 28 days 
(20 for α-SMA, 28 for TUBB3 and AFP) after particle and laser treatment. C) 
RT-PCR analysis of differentiation biomarkers in H9 cells 19 and 21 days after 
particle and laser treatment. MAP2: ectoderm; BRACHYURY: mesoderm; 
FOXA2, AFP, CDX2: endoderm. 
 
demonstrate that treatment using HRT and NIR laser does not change the ability of 
H9 cells to differentiate into all three germ layers (Figure III-17). 
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G. Summary 
We have successfully developed a strategy to control RNAi in human 
embryonic stem cells using a near-infrared laser. To achieve efficient uptake we 
developed a new modular design for hollow gold nanoshells that couples a targeting 
peptide to the siRNA. The nanoparticles each carry thousands of siRNA molecules 
and a streptavidin capsid, which when combined with the TAT peptide, efficiently 
penetrated into a broad range of hESC including H1, H7, H9 and H14. 
Internalization of the constructs was tracked and quantified by flow cytometry. 
Exposure to femtosecond pulses of NIR light caused GFP and Oct4 knockdown in 
hESC, and differentiation to all three germ layers, supporting the biocompatibility 
of this novel method. This strategy enables laser printing of siRNA in stem cells 
with cellular-level resolution at a desired time, and will hence offer new avenues in 
stem cell basic research and stem cell tissue engineering for regenerative medicine, 
for example as a tool to probe effects on tissue development. 
H. Materials and methods 
1. Cell culture 
The human embryonic stem cells H1, H7, H9 and H14 (WiCell Research 
Institute) were maintained on Matrigel (BD Biosciences) coated 6-well plates (BD 
Falcon) with mTeSR1 medium (Stem Cell Technologies) at 37 ˚C in 5% CO2. Cells 
were passaged by manual dissection without enzymatic dissociation every 5-7 days. 
For differentiation, H9 cells were cultured with differentiation medium (Dulbecco’s 
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modified Eagle’s medium (DMEM)/F12, 20% knockout serum replacement, 0.1 
mM MEM nonessential amino acid solution, and 0.1 mM β-mercaptoethanol (all 
from Invitrogen)). HEK293T cells (CRL-11268) and HeLa cells (ATCC) were 
maintained in DMEM supplemented with 10% fetal bovine serum. 50 µg/mL 
Normocin (InvivoGen) was supplemented in cell culture media.	
2. Lentiviral transfection of hESCs to transduce GFP gene and 
silence Oct4 gene 
Lentiviral vector pLVTHM-scramble (a gift from Dr. Zach Ma, UCSB) 
containing a eGFP tag was used to generate a transduced H9-GFP cell line. 
Lentiviral vectors LL-hOCT4i-1 and LL-hOCT4i-2 (Addgene #12197, #12198) 
were used for the expression of Oct4-shRNA in H9 cells. Lentiviral vector 
pLVTHM-scramble containing a non-targeting scrambled shRNA was also used as 
the negative control for Oct4 gene knockdown (shRNA: 
GCUUGUUCGUUGGUAACUACAUU). Lentiviral vector plasmids along with 
psPAX2 (Addgene #12260) and pMD2.G (Addgene #12259) were transfected into 
HEK293T cells to generate the viral particles. After 48 h and 72 h, supernatants 
were collected, filtered through a 0.22 µm filter, and concentrated by PEG-it 
(System Biosciences) precipitation and centrifugation at 1500×g for 30 minutes. A 
viral titer was performed by transducing Hela cells with several different dilutions 
of isolated virus. Passage 54-56 H9 cells were dissociated to cell aggregates (~20 
cells per aggregate) using cell dissociation buffer (CDB, Invitrogen) and plated on 
Matrigel-coated 6-well plates, and after seeding for one day, cells were incubated 
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with concentrated virus for another 24 h in the presence of 0.6 µg/mL polybrene 
(Millipore). Seven days post transduction, cell colonies were assayed for GFP or 
OCT4 protein expression. For generating stable H9-GFP cells, colonies with high 
GFP expression were manually dissected and screened for 2-3 passages.	
3. siRNA transfection of hESCs with commercial reagents 
Testing of commercially available transfection reagents Lipofectamine 2000 
(Invitrogen) and jetPRIME (Polyplus-transfection Inc.) in transduced H9-GFP cells 
was conducted by measuring GFP expression after GFP-siRNA (IDT EGFP-S1 DS 
Positive Control) transfection. Cells were dissociated using CDB buffer treatment 
and plated on a 24-well plate (5×104 cells per well) in the presence of ROCK 
Inhibitor (Y-27632, Millipore) at 10 µM. The following day the transfection was 
performed according to the manufacturer’s protocol: 1 µL of Lipofectamine 2000 or 
jetPRIME with 15 nM siRNA was added to each well following medium exchange 
(mTeSR1 + 10% FBS, no Normocin). After 24 h, the medium was replaced with 
fresh mTeSR1 medium. Cells were imaged by fluorescence microscopy three days 
after the transfection to assay GFP expression. 
4. siRNA coating on HGNs and TAT peptide functionalization 
Thiolated sense RNA or DNA strands (Table III-1, Biosearch) were 
assembled on HGNs followed by the hybridization of complementary strands 
(Table III-1, Biosearch) to form siRNA or DNA duplexes and the backfilling steps, 
using the protocol described in Chapter II-H (1-3). The siRNA sequences for GFP 
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and Oct4 gene knockdown are listed in Table III-1. Thereafter, a large excess (~1.5 
mg/mL) of NHS-PEG4-Biotin (Thermo SCIENTIFIC, #21362) dissolved in 50 µL 
DMSO was added to 1 mL ~0.1 nM HGN-dsDNA or siRNA to functionalize the 3’ 
end of thiol-DNA or -RNA with biotin. The solution was sonicated briefly and 
incubated for 1 h at RT, followed by washing with conjugation wash buffer twice to 
remove excess functionalizing reagent. All the nanoparticle washing steps were 
performed by centrifuging at ~7000×g for 10 minutes and resuspending the pellet in 
the respective buffer outlined below through brief sonication.  
Streptavidin (PROzyme) was then coated on biotinylated oligonucleotides 
on HGN to bridge between nucleic acid and biotinylated TAT peptide, by adding at 
1 mg/mL to ~0.05 nM nanoparticle in the presense of 0.5× PBST (DPBS with 0.1% 
Tween-20) and incubating at RT for 1 h after brief sonication. To avoid the particle 
self-aggregation that may be caused by streptavidin bridging, the solution was 
vortexed and sonicated immediately upon the addition of streptavidin. The 
sequential washing of particles with two kinds of buffer (assembly washing buffer 
and conjugation washing buffer) enhanced the nanoparticle monodispersity. HGN-
dsDNA or siRNA with streptavidin coating was finally coated with biotin-TAT (N-
terminal biotin, YGRKKRRQRRR, GenScript) to form the multivalent TAT 
peptide layer on the outside, of which biotin-TAT was added to ~0.05 nM 
nanoparticle twice at 15 µM in the presence of 0.5× PBST followed by brief 
sonication and 30 minutes incubation at RT. The nanoparticles were then 
sequentially washed with assembly washing buffer and conjugation washing buffer 
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again, and concentrated to ~0.3 nM by centrifugation at ~7000×g for 10 minutes 
and the pellet was resuspended in conjugation wash buffer. Particles with nucleic 
acid and TAT peptide coating were stored at 4˚C prior to adding to cells. 
5. Particle transfection and NIR laser irradiation to hESCs 
hESC including H1 (passage 38-40), H7 (passage 40-42), H9 (passage 60-
70), and H14 (passage 66-68) on 6-well plates were dissociated by rinsing and 
incubating with 500 µL PBS (Ca2+ and Mg2+ free, Invitrogen #10010-023) at 37 ˚C 
in 5% CO2 atmosphere for 10 minutes followed by manual dissection to suspend 
the cells. The suspended cell aggregates solution was added with 1 mL 
mTeSR1+10%FBS and pipetted gently with P1000 pipette for 10-15 times to 
further decrease the size of the cell aggregates. Thereafter, cells in the format of 
single cell or small cell aggregates (5-10 cells per aggregate) were centrifuged at 
145×g and resuspended in mTeSR1+10%FBS at ~2×106 cells/mL.  
13 pM of coated particles (after brief sonication) were added to 200 µL of 
cell suspension and incubated in 1.5 mL Eppendorf tubes at 37 ˚C for 2 h, with the 
gently pipetting of the solution by P1000 pipette for 5 times every 30 minutes. Cells 
were washed by adding 1.2 mL cold PBS, centrifuging at 55×g for 3 minutes and 
resuspending in 45 µL cold PBS. Tubes with ~50 µL of cell suspension were 
irradiated with 2.4 W/cm2 pulsed NIR laser for 15 s by the output of femtosecond 
Ti:sapphire regenerative amplifier (Spectraphysics Spitfire) with the same setup as 
described in Chapter II-H (8). The laser beam diameter was ~4 mm with the 
spectral range of 800 ± 6 nm, and the pulse duration was ~130 fs with the repetition 
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rate at 1 kHz. The cells were either used for fluorescence intensity measurements by 
flow cytometry or plated in Matrigel-coated 12-well plates (~2×105 cells per well) 
in the presence of 10 µM ROCK Inhibitor over the first 24 hours. 
6. Imaging of particles in hESCs 
hESCs were dissociated into single cells and small aggregates by PBS 
treatment as described above followed by seeding on a Matrigel-coated 4-well 
chamber Permanox slide (Lab-Tek #70400) (~4×104 cells per well) in the presence 
of 10 µM ROCK inhibitor. The next day, coated nanoparticles were added at 13 pM 
after the medium switch to mTeSR1+10%FBS, and the cells were incubated at 
37˚C in 5% CO2 atmosphere for 2 h. After that, cells were washed in PBS twice, 
fixed in 4% paraformaldehyde (PFA) (VWR International, LLC) in PBS, and 
washed in PBS again. Cell nuclei were stained using Hoechst 33342 (Sigma-
Aldrich). Samples were mounted with Gel/Mount (Electron Microscopy Science) 
and visualized under light and fluorescence microscopy.  
Dark-field scattering images were recorded using an Olympus BX51 upright 
microscope with a reflection-mode high numerical aperture darkfield condenser (U-
DCW, 1.2-1.4). A 100×/1.30 oil Iris objective (UPLANFL) was used to collect only 
the scattered light from the samples. Images were recorded using a QImaging 
Retiga-2000R Fast 1394 camera with RGB color filter module, while fluorescence 
images were taken under the mono module.  
Laser scanning confocal microscopy was performed using an Olympus 
Fluoview 1000, with 405 nm and 559 nm lasers under the presets of DAPI (blue) 
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and Quasar570 (red), in sequential linescan mode. 24 slices in Z-stack with 0.4 µm 
increments were obtained from a single cell scan, and images were then digitally 
assembled using Imaris software to generate the 3D construction image of cells.	
7. Flow cytometry analysis 
Fluorescence intensity of GFP expression, quantification of the particle 
internalization from the Quasar570 fluorescence label, and the 
immunocytochemistry staining levels of OCT4, SSEA and TRA-1-60 were 
measured using BD Accuri C6 flow cytometer with a flow rate of 14 µL/min. The 
gate was based on the lineage range of forward and side scattering plots, and 10,000 
gated events were collected for each sample. To assay particle internalization from 
Quasar570 and GFP expression, cells were dissociated into single cells with 
Accutase (Life Technologies) and collected to directly inject into the flow 
cytometer for analysis.  
OCT4, SSEA4 and TRA-1-60 protein quantification was performed by 
collecting cells in suspension and staining through immunocytochemistry as 
follows: cells were fixed in 4% PFA in PBS (4 ˚C, 20 minutes) after the 
dissociation of cells using Accutase. For OCT4 immunocytochemical staining, 
additional cell permeabilization was performed in 0.2% Triton-X-100 (Sigma-
Aldrich) with 0.1% bovine serum albumin (BSA) (Sigma-Aldrich) for 3 min. After 
washing in PBS with 0.5% BSA, approximately 200 µL of cell suspension 
containing 2×105 cells were incubated with primary antibodies OCT4 (Santa Cruz 
Biotechnology #sc-5279), SSEA4 (Millipore #MAB4304), and TRA-1-60 
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(Millipore #MAB4360) for 30 minutes at RT. Cells were then collected by 
centrifugation, washed in 0.5% BSA and incubated with secondary antibody Alexa 
Fluor 488 Goat-anti-Mouse IgG, IgM (H+L) (Invitrogen A10680) for 30 minutes at 
RT. Finally, cells were washed, resuspended in 200 µL PBS, and injected in flow 
cytometer for analysis. 
8. Immunocytochemistry of attached hESCs 
Attached hESCs in culture were washed with PBS, fixed with 4% PFA in 
PBS (4 ˚C, 20 minutes) and washed with PBS again. Cells were then permeabilized 
by incubating with the blocking solution [1% Goat Serum (Invitrogen) + 1% BSA 
(Sigma-Aldrich) + 0.1% NP40 (Sigma-Aldrich)] for 1 h at RT. Thereafter, cells 
were incubated with primary antibodies OCT4, βIII-tubulin (Sigma #T8660), α-
smooth muscle actin (Sigma #A5228) and α-fetoprotein (Santa Cruz Biotechnology 
#sc-166325) diluted in the blocking solution for 1 h at RT. After three PBS washes, 
all samples were incubated with secondary antibody Alexa Fluor 488 Goat-anti-
Mouse IgG, IgM (H+L) diluted in the block solution for 1 h at RT. Following the 
nuclei staining using Hoechst 33342, cells were imaged with an Olympus IX70 
inverted microscope.	
9. hESC cell viability assay 
The effect of particle internalization and NIR laser treatment to stem cell 
viability was assayed by cell coverage area analysis on plate after days. The treated 
or untreated control cells were seeded on Matrigel-coated 12-well plate at 2×105 
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cells per well and cultured using mTeSR1 medium for 5 days (in the presence of 10 
µM ROCK inhibitor in the first 24 hours). After washing with cold PBS twice, cells 
were stained with crystal violet (Sigma-Aldrich) solution (1% in PBS) for 10 
minutes, followed an additional four washes with PBS. Only the area covered by 
cells was stained. The wells were imaged by a digital camera and the images were 
analyzed the stained area using ImageJ software.	
10. Western blotting 
Cells in 6-well plate were lysed with RIPA lysis buffer (50 mM Tris, 150 
mM NaCl, 1% Triton, 0.5% deoxycholate, and 2 mM EDTA) supplemented with 
Complete Protease Inhibitor Cocktail (Promega) and harvested by manual 
dissection to dislodge the cells from the plate. The cell extract was collected in 1.5 
mL Eppendorf tube and incubated on ice for 30 minutes, followed by centrifugation 
at ∼12400×g, 4 ˚C for 20 minutes. Loading buffer (6×, 300 mM Tris-HCl, 0.01% 
w/v bromophenol blue, 15% v/v glycerol, 6% w/v SDS and 1% v/v beta-
mercaptoethanol) was added to the supernatant and boiled at 95 ˚C for 10 minutes. 
Samples were then run on a precast 10% SDS-PAGE gel (Bio-rad).  
Proteins on the gel were electro-transferred onto a nitrocellulose membrane 
(Bio-rad). The membrane was blocked with 5% BSA in PBST at RT for 30 minutes 
followed by 4˚C overnight incubation with primary antibodies OCT4 (Santa Cruz 
Biotechnology #sc-5279) and β-actin (Abcam #ab8227) diluted in 5% BSA-PBST 
buffer. The membrane was subsequently washed three times for 15 minutes using 
PBST and then incubated for 3 h at RT in 5% BSA-PBST with secondary 
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antibodies including Alexa Fluor 488 labeled goat anti-mouse IgG (Invitrogen 
#A11001) and Alexa Fluor 647 labeled goat anti-rabbit IgG (Invitrogen #A21244), 
followed by washing three times for 15 minutes using PBST. Images were acquired 
using a GE Healthcare Typhoon 9400 scanner system and the bands were analyzed 
using the scanner control software.	
11. Reverse transcription PCR 
Total cell RNA was extracted using RNeasy Mini Kit (QIAGEN #74104) 
according to the manufacturer’s instructions, and RNase-Free DNase Set (QIAGEN 
#79254) was used to remove genomic DNA contamination during the extraction. ~1 
µg total RNA from each sample was subjected to reverse transcription (RT) 
reaction using High Capacity RNA-to-cDNA kit (Life Technologies #4387406) 
following the manufacturer’s instructions. Final RT products were diluted 10 folds 
in water and PCR reactions were performed using GoTag Flexi DNA Polymerase 
(Promega #M8295). 1 µL of cDNA was added in a total volume of 25 µL 
containing 2 mM MgCl2, 1× PCR buffer, 0.2 mM deoxyribonucleotide 
triphosphates (dNTPs), 0.5 µM each of the primers (Table III-2, Integrated DNA 
Technology) and 0.625 unit of Taq DNA polymerase. The PCR settings for all the 
genes were as follows: 95 ˚C for 2 minutes, 30 cycles through 95 ˚C for 30 s, 59 ˚C 
for 30 s, and 72 ˚C for 30s, then extension at 72 ˚C for 5 minutes. Reaction for 
housekeeping gene GAPDH was run as control. 2 µL of the PCR mixture was 
electrophoresed on 8% Native-PAGE gel at 300 V for 1.5 h, followed by CYBER 
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Gold (Life Technologies, #S-11494) staining and imaging with the GE Healthcare 
Typhoon 9400 scanner system.			 	
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I. Appendix  
Table III-1. Oligonucleotides attached on HGNs. 
 
 
Table III-2. Primers used for RT-PCR. 
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IV. Cell-resolution RNA interference of 3D-cultured hESCs  
A. Abstract 
We describe the first method to regulate gene expression in human 
embryonic stem cells cultured in three-dimensional (3D) matrix with cell level 
resolution. Targeted cell(s) are discriminated from neighboring cell(s) by simply 
focusing the biologically benign near infrared light irradiated from a commonly 
available two-photon microscope. Irradiation of cells that have internalized hollow 
gold nanoshells releases surface attached small interfering RNA molecules and 
leads to concomitant downregulation of gene expression. The ability to induce 
light-mediated gene knockdown persists for at least two days, offering a time 
window for temporal control. We anticipate that this level of gene control within a 
subpopulation of cells in 3D culture will significantly improve the ability to direct 
in vitro organogenesis using pluripotent stem cells, and provide a powerful 
technique for various in vivo biological studies. 
B. Introduction 
Biological processes are stimulated by various molecular and physical 
signals orchestrated in space and time [1-4]. Tissue and organ generation in vitro 
for transplant therapy and disease modeling for drug screening [5] are especially 
demanding for precise control over 3D patterning of different cell types [2, 4, 6, 7]. 
Advances in this area include the controlled differentiation of pluripotent or 
multipotent stem cells cultured in 3D matrices followed by self-organization into 
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tissues in vitro [1, 8-11]. However, current methods for organoid formation have 
insufficient control over the course of the morphogenetic processes and the 
resulting structures inadequately replicate native tissues [2, 4]. Microfluidic 
approaches establish organ-level functions ex vivo by directly assembling different 
cell types, but lacks the dimensionality to approximate the developing tissues [2]. 
Nanotopographic patterning provides spatial control of stem cell differentiation, but 
is mostly restricted to a two-dimensional plane, limiting the repertoire of cell types 
generated [12-14]. 
Light is an ideal stimulus for perturbing the spatiotemporal dynamics of 
signals in living cells and organisms with high resolution [15-17]. The light-based 
optogenetic field has moved from proof of concept to answering real biological 
questions [16], as well as developed tools for light-controlled genome editing and 
gene transfection [18-22]. However, current optogenetic gene regulation methods 
rely largely on the visible light excitation sources and the construction of complex 
protein fusions via viral transfection. Other alternatives use photocaged small 
molecules and biopolymers like DNA and RNA for light-dependent gene regulation 
[4, 15, 23-26], which are limited by cellular delivery hurdles and the use of low 
tissue-penetrating UV-Vis light [15-17]. 
Herein, we develop a novel pulsed NIR light based technique for the spatio-
temporal control of gene regulation in 3D-cultured hESCs. NIR light can be tightly 
focused three-dimensionally (down to ~1 femtoliter) [27] and can reach deep 
through tissues [28, 29]. In this method, siRNAs are covalently attached to HGNs 
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[30-32] presenting a cell-penetrating TAT peptide [33]. Biocompatible NIR light 
irradiation of the nanoparticles in intended cells releases the RNAs from the 
nanoparticle surface and from endosomes into the cytosol to selectively regulate 
gene expression. In this work, we use a commonly available two-photon 
microscope to focus the NIR laser three-dimensions as a means to carry out cell 
level RNA interference within 3D hESC “spheroids” cultured in a synthetic 
thermoreversible hydrogel [34]. We demonstrate selective, cell level resolution 
GFP-siRNA release in 3D-cultured hESCs patterned by NIR light irradiation, with 
no detrimental effects on cell viability or developmental potential. This light-
controlled gene silencing lasts for up to 2 days, providing a time window for spatio-
temporal control. This cell resolution RNAi technique provides a novel, powerful 
means for investigating stem cell differentiation and organogenesis in vitro and in 
vivo in model organisms. 
C. Nanoparticle transfection of hESC spheroids in a 3D matrix 
In order to regulate gene expression in specific hESC spheroids or a 
subpopulation of cells in 3D culture, we utilized a two-photon microscope 
(Olympus Fluoview 1000 MPE) to achieve cell level resolution control of NIR light 
in combination with the technique we pioneered on NIR-light activated siRNA 
delivery in hESCs [33]. Many copies of siRNA molecules were assembled on 
HGNs and taken up efficiently by hESCs through TAT peptide mediated 
endocytosis. Cell clusters formed during particle incubation in the presence of 
ROCK inhibitor and were switched into a thermoreversible hydrogel (Mebiol® Gel,  
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Figure IV-1. Spatio-temporally controlled cell resolution gene silencing in 
3D-cultured hESCs using HGNs and two-photon microscopy. GFP-expressing 
hESCs internalized with siRNA-coated HGNs are switched to a medium 
containing the thermoreversible Mebiol gel in the liquid phase. The mixture is 
cast as a thin layer (~100-150 µm) of solid-phase gel on a petri dish with a grid 
on the bottom to allow tracking of individual clusters over time. Cellular 
clusters or regions within clusters are irradiated with 800 nm laser emitted by 
a two-photon microscope at selected x, y and z positions. Cells treated with 
laser are re-located and imaged 3 days after laser irradiation to assess the 
light-released siRNA activity. 
		
Cosmo Bio Co.), which was then solidified at 37oC. 800 nm femtosecond pulsed 
laser from the two-photon microscope was then focused at selected x, y and z 
regions of cell clusters to bring local release of siRNA to the cytosol for gene 
silencing (Figure IV-1). This strategy allows selective gene regulation within 3D 
cell assemblies, at cell level resolution. 
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Figure IV-2. The addition of ROCK inhibitor during particle incubation 
significantly increases stem cell viability in the 3D matrix and prompts cell 
aggregation, with no inhibition on particle internalization. A) Schematic of the 
protocol for casting traceable 3D-cultured stem cell steroids before two-photon 
microscope imaging and 800 nm laser irradiation. B) Flow cytometry analysis 
of nanoparticle internalization efficiency with the addition of RI during the 
nanoparticle incubation process. C) Cell viability test of H9 cells cultured in 
the 3D matrix for 3 days post particle incubation. Cells from 3D culture are 
collected and seeded on Matrigel-coated 6-well plate for additional 2 days, 
followed by the cell viability staining using violet blue.  
		
In prior work we showed that a wide variety of hESC lines can be efficiently 
transfected with HGNs coated with TAT peptide. However, only a small fraction of 
these single cells survived when switched into the Mebiol gel for 3D culture, which 
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may be caused by unfavorable culture conditions during HGN transfection steps. 
Shortening the HGN incubation time resulted in decreased internalization. Because 
ROCK inhibitor rescues stem cell viability of single cell formats in a 3D matrix 
[34], we tested the addition of this during HGN incubation (Figure IV-2A). 
Notably, ROCK inhibitor significantly increased the amount of viable cells in 3D 
matrix without detectable inhibition of HGN internalization (Figure IV-2B,C). We 
also observed that dissociated single cells aggregate into cell clusters with ROCK 
inhibitor treatment (Figure IV-2C), forming cellular spheroids within 3 days. Cells 
irradiated with NIR light were analyzed for gene expression after 3 days, and the 
cell-containing hydrogel was casted into a thin layer (100-150 µm thick) on grid-
bottomed culture dishes (Ibidi Co.) to track the cells.  
We also tested an alternative HGN transfection approach in which particles 
were supplemented while the developing of hESCs from single cells to spheroids in 
3D culture. Fresh medium containing HGNs were fed to gel-encapsulated cells 
every day to overcome any inefficiency of HGN penetration to inner cells of 
spheroids [35]. As a result, HGNs distributed equally across the whole body of 
cellular spheroids generated in the thin hydrogel layer (Figure IV-3). Although we 
relied largely on transfecting HGNs prior to 3D casting, the alternative method 
clearly has the advantage in particular circumstances. 
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Figure IV-3. Efficient nanoparticle transfection can also be achieved by 
casting stem cells in a thin Mebiol gel layer with nanoparticles supplemented 
daily in the medium on top. A) Schematic for two strategies of nanoparticle 
transfection for 3D-hydrogel supported stem cells. Cells are cast either in the 
thick “Dome” shape or “Thin layer” shape gel with nanoparticles-containing 
medium replenished every day during the culture. B) Flow cytometry assay of 
cells 1 day after nanoparticle transfection shown in scheme (A). C) 3D image of 
stem cells obtained by confocal fluorescence microscopy 3 days after 
nanoparticle transfection via the “Thin layer” strategy. Red puncta: 
Quasar570 on siRNA; grey: cell outline. 
		
D. Light-activated GFP knockdown in transduced hESC spheroids 
hESC H9 cells were transduced with the GFP gene to test the light-
controlled GFP-siRNA delivery using the two-photon microscope equipped with 
both single-photon confocal mode and two-photon mode. Following optimization 
using 2D-cultured HeLa cells (Figure IV-4), NIR laser irradiation was performed 
using the two-photon mode through z-stacks of the cell cluster with 1.4 µm 
intervals, and each z-stack (512 × 512 pixels) was scanned line-by-line (2 µsec per  
 92 
Figure IV-4. NIR laser power optimization for maximum gene silencing 
effect in GFP gene transduced HeLa cells. The femtosecond pulsed laser 
emitted by the two-photon microscopy is optimized the irradiation intensity at 
3%, 5% or 8% of the maximum power with 2 or 4 µsec/pixel. Laser power at 
3% with 4 µsec/pixel does not release enough siRNA, whereas 8% with 4 
µsec/pixel causes some cell morphology change immediately (red arrow) as a 
sign of cell damage. 5% (~2 mW) with 2 µsec/pixel is the optimized laser 
treatment condition with the best knockdown effect but the least cell damage. 
 
selected pixel, 5% of the maximum power), a total of 5 times. Single-photon 
confocal imaging was used to reference siRNA release and immediate cellular 
effect before and after the 3D-selected irradiation in the two-photon mode. Laser  
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Figure IV-5. GFP gene knockdown of 3D-cultured hESC H9 cell clusters 
by NIR light irradiation. A) Confocal fluorescence microscopy (in single-
photon mode) of H9-GFP clusters before and after 800 nm laser irradiation (in 
two-photon mode) compared to non-irradiated control cluster. B) Fluorescence 
imaging of the same H9-GFP spheroids shown in (a) 3 days post laser 
irradiation. C) Averaged GFP intensity of spheroids (3D pixel intensity 
analysis) 3 days post laser treatment. 
		
irradiation of hESC H9 cell clusters in the 3D hydrogel stimulated the release of 
siRNA from internalized HGNs to cytosol, indicated by the brighter and diffused 
red puncta of Quasar570 (labeled on siRNA) fluorescence after laser irradiation 
(Figure IV-5A). siRNAs activated by laser treatment successfully down regulated 
GFP expression (Figure IV-5B,C).  
 94 
Figure IV-6. NIR laser irradiation to HGNs-internalized H9 clusters in 3D 
hydrogel at optimized condition has no inhibition to cell growth, compared to 
no laser control. Assessed by 3D volume analysis, cell clusters treated with 
HGNs and laser have the same magnitude of size increase as no laser control 
after 3D culture for 3 days. NS: not significant by student t-test.  
		
Cells irradiated with the NIR laser grew at the same rate of cells without 
laser treatment and showed no difference in viability (Figure IV-6). HGN mediated 
GFP-siRNA delivery to mCherry co-transduced H9 cells resulted in selective GFP 
knockdown without any detectable changes in mCherry expression, further 
confirming the specificity of GFP knockdown (Figure IV-7). Markers for cell 
pluripotency were also probed by immunocytochemistry of cells treated with HGNs 
and an equivalent NIR laser (femtosecond Ti:sapphire regenerative amplifier, 130 
fs pulse duration, 1 KHz repetition rate) with ~4 mm beam diameter covering the 
whole 3D hydrogel. Similar levels of OCT3/4 and TRA-1-60 were observed in cells 
treated with HGNs and laser compared to the cell only control and cells treated with 
HGNs but not laser (Figure IV-8). Thus, this approach is highly biocompatible. 
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Figure IV-7. Selective GFP knockdown of H9 spheroid co-transduced with 
GFP and mCherry genes in a 3D matrix. Fluorescence microscopy of A) GFP 
and B) mCherry expression in H9 spheroids 3 days after the laser treatment. 
C) Merged image of (A) and (B). D) Mean GFP and mCherry fluorescence 
intensity of spheroids 3 days post laser treatment, assayed from the 3D pixel 
intensity analysis of the cell body region in A) and B). 
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Figure IV-8. NIR laser irradiation of H9 cells in 3D matrix does not affect 
cell stemness. Flow cytometry of H9 cells stained with OCT3/4 (A) and TRA-1-
60 (B) antibodies 3 days post NIR laser treatment in 3D hydrogel followed by 1 
day culture on Matrigel plate. Cells treated with HGNs and an equivalent 
pulsed NIR laser (~130 fs pulse duration, repetition rate at 1 KHz) with 4 mm 
beam have similar levels of OCT3/4 and TRA-1-60 surface marker expression 
as those of cell only control and cells treated with HGNs but not laser. 
		
E. Spatially controlled gene silencing 
NIR laser activation of a subpopulation of cells within one cell cluster 
provides unprecedented spatial control. In Figure IV-9, red puncta (Quasar570 
fluorescence labeled on siRNA) in the irradiated areas are brighter and more diffuse 
than surrounding areas, indicating high resolution control of siRNA release guided 
by the x, y and z laser scanning from the two-photon microscope. Interestingly, 
although the spheroid retained a similar shape three days after laser treatment, GFP 
fluorescence of the whole cellular spheroid showed different downregulation 
patterns: edged, mosaic, and retrograde (Figure IV-10A). In contrast, GFP- 
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Figure IV-9. Spatially controlled siRNA delivery in hESC spheroids with 
cell level resolution. A) NIR laser patterned siRNA release (in frames) on a cell 
free glass slide. B) Laser controlled cell resolution siRNA release (in yellow 
frame) within one cell cluster in a 3D matrix. 
		
transduced HeLa cells loaded with HGNs and irradiated on a 2D culture dish 
showed down-regulated GFP expression, but stayed in the original region outlined 
by the laser (Figure IV-10B). This suggests that undifferentiated H9 cells migrate 
[36] within the spheroid, and laser irradiation and siRNA release does not inhibit 
migration (Figure IV-10). We anticipate that as selected cells differentiate, 
migration may be restricted to allow for the formation of certain spatial patterns and 
morphologies [1, 10]. 
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Figure IV-10. Spatially controlled gene silencing in hESC spheroids and 
2D-cultured HeLa cells with cell level resolution. A) 3D-cultured H9 spheroids 
with a subpopulation of cells treated with GFP-siRNA show different GFP 
down-regulation patterns 3 days later: edged, mosaic and retrograde. Top 
panel: Cells within the yellow dashed line cubes are irradiated with laser; 
Middle and Bottom panel: GFP fluorescence images of cellular spheroids 
before and after laser treatment for 3 days. B) 2D-cultured HeLa cells show 
similar patterns of GFP down-regulation 3 days later as outlined by the laser 
irradiation. siRNA molecules are labeled with Quasar570 dye (red); GFP 
fluorescence (Green); Cell outline (grey). 
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F. Temporally controlled gene silencing 
The timing of siRNA activation can also be tuned by laser irradiation. 
Cellular spheroids were irradiated with NIR laser 2 hours (Day 0), 1 day, 2 days 
and 3 days post HGN incubation and 3D hydrogel placement. Functionalized HGNs 
exhibited laser-dependent release of functional siRNA up to 2 days after cellular 
uptake, while no siRNA activity was observed when the time lag extended to 3 days 
(Figure IV-11A,B). Consistently, the siRNA signal (by Quasar570 fluorescence) in 
the 3D-cultured H9 cells dramatically drops 2 days after particle incubation (Figure 
IV-12). We carried out similar experiments with HeLa cells transduced with GFP 
(~24 hour doubling time [37]) to explore why gene silencing is lost after three days. 
However, laser irradiation 3 days post HGN internalization still showed effective 
gene silencing (Figure IV-11C and Figure IV-13), indicating loss in siRNA 
knockdown is likely due to rapid siRNA degradation in hESCs rather than dilution 
by cell division.  
We found that the siRNA on the HGNs remain intact in buffer at neutral pH 
for at least a month, whereas overnight exposure to glutathione (GSH) at 0.01 mM 
releases half of the siRNA (Figure IV-14). Thus, siRNA may be displaced by 
cellular GSH evidenced by brighter and diffused signals from siRNA label one day 
after HGN internalization (Figure IV-12). However, considering that the endosome 
is another barrier to be ruptured by the thermal response of HGNs to laser, 
irradiation is still the “power on button” for siRNA activity (Figure IV-11). This 
provides the basis for the spatial control of siRNA release over time. 
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Figure IV-11. Temporally controlled gene silencing in 3D-cultured H9 cells 
and 2D-cultured HeLa cells. A) Fluorescence imaging of GFP (green) in 3D-
cultured H9 spheroids (grey for cell outline) 3 days post laser irradiation. 
Cellular spheroids were irradiated with 800 nm laser using the two-photon 
microscope 2 hours (Day 0), 1 day, 2 days and 3 days after HGN incubation. B) 
Averaged GFP fluorescence intensity of H9 spheroids in (A) from the 3D green 
pixel intensity analysis within the cell outline. C) Averaged GFP fluorescence 
intensity (pixel intensity analysis) of 2D-cultured HeLa cells 3 days post laser 
irradiation exposed to cells 2 hours (Day 0), 1 day, 2 days and 3 days after 
particle incubation. *, p < 0.5; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. 
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Figure IV-12. siRNA-loaded nanoparticles show longer lifetimes in HeLa 
cells than hESC H9 cells after the cellular uptake. Fluorescence imaging of 
Quasar570 (red, labeled on HGN-siRNA) in A) 3D-cultured H9 spheroids 
(grey for cell outline) and B) 2D-cultured HeLa cells 2 hours (Day 0), 1 day, 2 
days and 3 days post nanoparticles incubation. siRNA signal in 3D-cultured 
H9 cells drops dramatically 2 days after particle incubation, while the drop in 
HeLa cells is comparatively less. The increase of fluorescent signal (brighter 
and diffuse) in both H9 cells and HeLa cells 1 day post HGNs internalization 
could be due to the displacement of thiolated siRNA on gold surface by 
reducers in cells like glutathione (GSH). 
		
 102 
Figure IV-13. siRNA molecules carried by HGNs in HeLa cells for 3 days 
retain the gene silencing activity upon laser-induced release. siRNA release 
and GFP knockdown in HeLa cells irradiated with 800 nm laser 2 hours (day 
0), 1 day, 2 days and 3 days post nanoparticle incubation. Area in white line: 
laser irradiated area, Q: Quasar570, BF: Brightfield. 
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Figure IV-14. siRNA molecules remain intact on HGNs in HEPES buffer at 
neutral pH and for 3 hours with 1 mM glutathione, whereas longer exposure 
times and higher glutathione concentrations result in siRNA release at 37oC. 
The total loading of Quasar570-labeled siRNA on HGNs was determined by a 
fluorescence-based method after the complete release of the oligonucleotides 
through KCN etching. The dissociated population of siRNA from HGNs A) 
over time in HEPES buffer (10 mM HEPES, 1 mM Mg2+, 0.01% Tween-20) at 
4oC and B) in HEPES buffer with varying concentrations of GSH for 3 hours 
or overnight at 37oC. 
		
G. Summary 
In summary, we have developed a novel approach to control gene regulation 
in human embryonic stem cells in a 3D matrix with unprecedented spatio-temporal 
control. The protocol results in efficient siRNA-carrying HGN transfection in three-
dimensional multicellular clusters with high viability. A thermoreversible synthetic 
hydrogel was used as the matrix for hESC 3D culture and NIR light 3D-patterned 
irradiation operated by a two-photon microscope. We demonstrated three-
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dimensional cell resolution siRNA release in selected cells upon laser irradiation, 
and observed GFP-siRNA activity by tracking the irradiated cells for GFP 
fluorescence analysis after further culture for 3 days. The GFP gene silencing of a 
subpopulation cells showed distinct patterns of downregulation, suggesting 
significant cell migration of undifferentiated hESCs within 3D spheroids. This 
approach is viable for at least two days after HGN treatment, providing a basis for 
spatio-temporal control. The cargo spectrum of this method can easily be expanded 
to microRNA and gRNA (for CRISPR/Cas9 mediated gene editing) for both 
downregulation and up regulation of genes. Thus, the method provides a novel basis 
for spatio-temporally controlled gene regulation in pluripotent stem cells for in vitro 
organogenesis. Moreover, the two photon excitation approach can also be combined 
with in vivo imaging [38] to become a promising means for investigation of 
developmental processes in vivo.	
H. Materials and methods 
1. Cell culture on 2D petri dish 
hESCs including H9 (passage 60-70, WiCell Research Institute), transduced 
H9-GFP (passage 65-75) and H9-GFP/mCherry (passage 75-85) were maintained 
on Matrigel (BD Biosciences) coated plates (BD Falcon) in mTeSR1 medium 
(Stem Cell Technologies) at 37˚C in 5% CO2 atmosphere. Cells were passaged by a 
non-enzymatic manual dissection every 5-7 days. HeLa (ATCC) and HEK293T 
cells were cultured in DMEM (Hyclone) supplemented with 10% fetal bovine 
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serum (FBS, Hyclone). 50 µg/mL Normocin (InvivoGen) was supplemented in cell 
culture media.	
2. Generation of stably transfected hESCs and HeLa cells 
In order to generate transduced H9-GFP and H9-GFP/mCherry and HeLa-
GFP cell lines, lentiviral vectors pLVTHM-scramble (containing an eGFP tag, a 
gift from Dr. Zach Ma, UCSB) and pLV-mCherry (Addgene #36084) were used.	
Viral particles were generated using the protocol described in Chapter III-H (2). A 
viral titer was performed by transducing HeLa cells with several different dilutions 
of isolated virus. HeLa cells with the best transfection efficiency from virus 
containing pLVTHM-scramble vectors were passaged for 3 times and freeze-
stocked as stable HeLa-GFP cell line.  
Passage 54-56 H9 cells (for pLVTHM-scramble vector transfection) or 
Passage 64-66 H9-GFP cells (for pLV-mcherry vector transfection) were 
dissociated to cell aggregates (~20 cells per aggregate) using cell dissociation 
buffer (CDB, Invitrogen) and cultured on Matrigel-coated 6-well plates for 24 
hours. The next day fresh medium containing concentrated virus titrated from 1:1 to 
10:1 (virus to cell ratio) and 0.6 µg/mL polybrene (Millipore) was added and 
incubated for another 24 hours. Seven days post transduction, cell colonies were 
fluorescence-imaged for GFP and mCherry expression. For generating stable H9-
GFP and H9-GFP/mCherry cells with high and homogeneous fluorescent protein 
expression, colonies were manually screened for continuous 3 passages according 
to the fluorescence imaging.	
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3. hESC culture in a 3D thermoreversible hydrogel 
Each well of 2D-cultured hESCs on 6-well plates were dissociated by 
incubating with 500 µL PBS (Ca2+ and Mg2+ free, Invitrogen #10010-023) at 37˚C 
in a 5% CO2 atmosphere for 10 minutes followed by manual dissection to suspend 
the cells. The suspended cell aggregate solution was added to 1 mL mTeSR1 and 
pipetted gently 10-15 times with a P1000 pipette to further decrease the size of the 
cell aggregates (~most optimal with 5-10 cells per aggregate). Thereafter, ~4×105	
cells in single cell or small cell aggregates were mixed with 200 µL PNIPAAm-
PEG (Mebiol Thermoreversible Hydrogel, Cosmo Bio) dissolved in E8 medium 
(Stem Cell Technologies) at 4˚C using a positive-displacement pipette (Microman 
M250, Gilson).  
100 µL of homogenized cell solution was then transferred onto the grid area 
of an ice-chilled petri dish (µ-Dish35mm Grid-500, Ibidi) to cover the whole surface 
as a thin layer of liquid (~100-150 µm), followed by the incubation at 37˚C for 5 
minutes to solidify the hydrogel. 3 mL of warm E8 medium containing 10 µM 
ROCK inhibitor was then added on top of the hydrogel and refreshed every day 
during the subsequent 3D culture. To collect cells from 3D hydrogel after a period 
of culture, 1 mL ice-cold PBS was replaced on the hydrogel layer and incubated at 
4˚C for 5 minutes to dissolve the hydrogel, followed by the centrifugation at 145 × 
g for 3 minutes.	
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4. Nanoparticle transfection protocol 
Nanoparticle preparation protocols including HGN synthesis, siRNA 
loading and TAT peptide functionalization are described in Chapter II-H (1-3) and 
Chapter III-H (4). The siRNA sequences (siGFP and siRFP) for GFP and mCherry 
gene knockdown are listed in Table IV-1. Cells were transfected with coated 
particles in suspension prior to hydrogel embedment to achieve efficient 
internalization of nanoparticles throughout the cell clusters in 3D culture. Cells on 
6-well plates were suspended and dissociated into single cells or small cell 
aggregates using the treatment of Ca2+ and Mg2+ free PBS as described above. Cells 
were centrifuged at 145 × g and resuspended in 200 µL particle containing 
transfection medium (mTeSR1 + 10% FBS + 10 µM ROCK inhibitor + 13 pM 
HGNs) at ~2 × 106 cells/mL, followed by 37˚C and 5% CO2 incubation for 2 hours 
with gentle pipetting of the solution by P1000 pipette for 5 times every 30 minutes. 
Thereafter, cells were washed by adding 1.2 mL cold PBS and centrifuging at 55 × 
g for 3 minutes, followed by the resuspension in 200 µL ice-cold PNIPAAm-E8 
solution. 100 µL of the cell mixture was transferred to the grid petri dish and 
solidified at 37˚C for 5 min before the addition of ROCK inhibitor containing 
medium, as described above. 
As an alternative way of particle transfection, dissociated and suspended 
hESCs from 2D culture were cast in a thin layer of 3D Mebiol gel on grid petri dish 
as described above, followed by the daily feeding of fresh HGN-containing medium 
(E8 + 10% FBS + 10 µM ROCK inhibitor + 13 pM HGNs) for 5 days. 
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For the transfection of 2D-cultured HeLa-GFP cells, ~1 × 105 cells were 
plated on grid petri dish one day in ahead, and the next day fresh medium (DMEM 
+ 10% FBS) containing 6.5 pM HGNs were replaced and incubated at 37˚C in 5% 
CO2 for 2 hours. After that, cells were washed twice with fresh medium. 
5. Two-photon microscope excitation and imaging 
To activate the siRNA function, 2D-cultured HeLa cells and 3D-cultured H9 
cells on grid petri dish post HGN transfection were irradiated with a pulsed NIR 
laser generated by a two-photon microscope (Olympus Fluoview 1000 MPE) with 
environmental chamber adjusted at 30˚C and 5% CO2 atmosphere. The two-photon 
microscope is equipped with a 25 × water immersion objective (numerical aperture 
1.05), a mode-locked titanium-sapphire femtosecond (fs) tunable (690-1020 nm) 
pulsed laser (100 fs pulse duration, 80 MHz repetition rate, MaiTai HP, Newport-
Spectra physics), 473 nm / 559 nm / 633 nm laser diodes, a transmitted light 
detection system, and a scan head controlled by the Fluoview software. The MaiTai 
laser was tuned to 800 nm at 5% of the maximum power (~2 mW) and exposed to 
z-stacks (1.4 µm interval) of intended cell(s) through line-by-line scanning (125 
KHz) of selected pixels in each z-stack (512 × 512 pixels, 0.331 µm per pixel) at 2 
µsec per pixel for 5 repetitions. The specimen was imaged in a single-photon 
confocal mode with the blue (for GFP) and green (for Quasar570 or mCherry) laser 
diodes at a scan speed of 80 KHz before and after the exposure to the MaiTai fs 
laser to compare the fluorescence signal difference caused by the laser treatment.  
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Cell(s) treated with laser or without laser were relocated after 3 days 
according to the grid information on the bottom of the petri dish, and imaged in the 
single-photon confocal mode for GFP, mCherry or Quasar570 fluorescence, as well 
as brightfield images from the transmitted channel.	
6. Image quantification and statistical analysis 
3D images obtained from the single-photon confocal mode of the two-
photon microscope were analyzed the GFP, mCherry and Quasar570 fluorescence 
intensity of cellular spheroids using Imaris 8.1 software (Bitplane). The 3D surface 
of spheroid was modeled according to the brightfield images and the volume was 
measured as an indication of cell growth. GFP and mCherry fluorescence intensity 
were averaged by the volume for the comparison of gene silencing effect with and 
without laser. Images of HeLa cells from 2D culture on petri dish were analyzed the 
GFP fluorescence intensity using ImageJ software and averaged by the area. 
Data with error bars are from at least three replicate experiments and are 
presented as the mean ± standard deviation (SD). Statistical analyses were done 
using the statistical package Instat (GraphPad Software), and the means of 
replicates were evaluated using t-tests.	
7. Flow cytometry analysis 
Particle internalization efficiency was assayed the fluorescence intensity 
from the Quasar570 label, using a BD Accuri C6 flow cytometer. The protocol and 
parameter setup are the same as described in Chapter III-H (7).  
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To assay for H9 cell stemness features upon laser irradiation in 3D 
hydrogel, OCT4 and TRA-1-60 protein levels were determined by 
immunocytochemical (ICC) staining. HGN internalized H9 cells in 3D Mebiol gel 
were irradiated with 2.4 W/cm2 pulsed laser for 15 s by the output of a femtosecond 
Ti:sapphire regenerative amplifier (Spectraphysics Spitfire) with the same set up 
described in Chapter II-H (7). The laser beam diameter was ~4 mm with the 
spectral range of 800 ± 6 nm, and the pulse duration was ~130 fs with the repetition 
rate at 1 KHz. Thereafter, cells were 3D cultured for 3 days, released from the 
hydrogel to mTeSR1 medium, and seeded on Matrigel-coated 6-well plate. The 
next day expanded cell colonies on 2D plate were dissociated into single cells using 
Accutase and fixed using 4% PFA in PBS (4˚C, 20 minutes). OCT4 and TRA-1-60 
ICC staining protocols are described in Chapter III-H (7). Stained cells in 200 µL 
PBS were injected into flow cytometer for analysis. 
8. hESC cell viability assay 
H9 cells on 2D plate were washed twice with cold PBS, incubated with 1% 
crystal violet (Sigma-Aldrich) solution in PBS for 10 minutes, and washed four 
times with PBS. The wells were imaged by a digital camera (Samsung Galaxy S4).	
9. Fluorescence-based siRNA coating assay 
Quassar570-labeled siRNA on HGNs were quantified by a fluorescence-
based assay. The siRNA-coated HGNs were etched by KCN to totally release the 
oligonucleotides (Caution: KCN should not be exposed to acidic conditions due to 
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cyanide gas evolution; prepare all solutions in 0.1 M NaOH). The standard linear 
calibration curve was made between Quasar570-labeled RNA concentration and 
fluorescence intensity in solution detected from a Tecan infinite 200 plate reader. 
The fluorescence signal in solution released from HGNs over time or by KCN 
etching was converted to RNA concentration using the calibration curve. 
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I. Appendix 
Table IV-1. Oligonucleotides used. 
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V. Modular surface functionalization for maximized siRNA 
delivery 
A. Abstract 
We describe a universal surface module and several functionalization rules 
for the maximized delivery of short nucleic acids (herein siRNA) in diverse human 
cells using gold nanocarriers. Streptavidin is devised as a handle to assemble 
biotinylated cell penetrating peptides (e.g., TAT) as well as an insulator from the 
dense negative charge of RNA. However, direct linking of streptavidin to functional 
siRNA inhibits its bioactivity. Our approach then evolves to the orthogonal 
assembly of two RNA strands: one with biotin modification for cell targeting and 
penetration (scaffold RNA); the other without biotin as functional RNA (siRNA). 
Single-stranded RNA is advantageous for densely surface-packing due to their high 
flexibility, but later a double-stranded format is preferred to best assemble the 
targeting peptide for cellular uptake and siRNA delivery. This orthogonal approach 
on the delivery of short oligonucleotides, together with novel surface 
functionalization rules discovered here, should be suggestive for nano-medicinal 
research and applications.	
B. Introduction 
Short oligonucleotides with ~20-60 nucleotides including siRNA, miRNA, 
antisense DNA and gRNA (for CRISPR) are powerful tools for gene regulation in 
many applications such as basic cell research, cancer therapy and regenerative 
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medicine [1-6]. The cellular delivery of these biologically unstable, high molecular 
weight, and negative-charged molecules remains a significant challenge [7, 8]. 
Diverse nanoparticles, including gold nanoparticles, have been used to assemble 
and stabilize siRNA from degradation and enhance cellular delivery [9-14]. 
Thiolated oligonucleotides have been self-assembled on the nanoparticle surface 
through the formation of quasi-covalent gold-thiol bonds [15-18]. The introduction 
of plasmonic gold nanoparticles with strong near-infrared light absorption, like 
nanorods, nanostars, and nanoshells, facilitates the release of siRNA after cellular 
uptake with high efficiency and remote light control [17, 19-24]. Importantly, the 
delivery of RNA cargoes can be easily attained at single cell-level resolution using 
a two-photon microscope without any detectable impact on cellular viability.   
Critical obstacles to the use of siRNA in a variety of human cells, including 
primary cells and embryonic stem cells, through nanoparticle platforms include 
efficient uptake as well as endosomal release [25]. The trans-activating 
transcriptional activator (TAT) peptide is highly efficient at guiding extracellular 
molecules to many cell lines [23, 26-28], but it is rarely used on nucleic acid coated 
nanoparticles [29] due to aggregation issues related to the polyelectrolyte charge 
interactions. In prior work with HGNs, we introduced streptavidin [30-33] as a 
relatively large and more neutrally charged spacer between the nucleic acid layer 
and TAT peptide outer layer [19]. The resulting nanoparticles formed a stable 
colloid and showed high penetration efficiency in a wide range of human  
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Figure V-1. Modular design of hollow gold nanoshells (HGN) for siRNA 
delivery. 
		
embryonic stem cells [19]. Herein, we devised a strategy to separately control the 
streptavidin coverage for efficient cell penetration while retaining a robust method 
to down regulate target genes, based on the mixed-assembly of a biotinylated thiol-
RNA and a non-biotinylated thiol-RNA on HGNs (Figure V-1). Importantly, the 
biotin-modified RNA assembles streptavidin noticeably better in the duplex form, 
leading to dramatically higher cell penetration efficiencies. Furthermore, using 
RNA for surface hybridization leads to improved efficiencies when compared to 
DNA (Figure V-1). The relationships between surface modifications and cellular 
performance of the materials described here may be important for the use of 
nanoparticles for the cellular delivery of nucleic acids.	
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C. Streptavidin coverage determines particle internalization efficiency 
We previously developed a strategy to deliver RNA-coated HGNs [17] into 
cells, by incorporating a streptavidin layer attached with the cell penetrating peptide 
TAT (YGRKKRRQRRR). TAT is well known for its efficient internalization into a 
broad range of mammalian cells, including cancer cells and stem cells [19]. 
Streptavidin acts as a charge insulator between the RNA and TAT peptide layer, 
reducing potential aggregation while serving as a convenient attachment site for a 
biotinylated peptide. This strategy generated HGNs in a stable colloid format with 
efficient cell penetration properties and laser-induced release of RNA caused 
knockdown of a reporter gene in the cells [19]. 
Here we find that using a biotin pre-modified RNA strand leads to higher 
loading of streptavidin (Figure V-2A), while bypassing the surface biotin 
functionalization step; this improves the cell internalization in both cancer (HeLa) 
and stem (hESC H9) cells (Figure V-2B). The relative streptavidin coverage level 
was estimated by a fluorescence-based assay of Oregon Green 488-labeled 
neutravidin due to their similar isoelectric point and binding affinity [34]. Varying 
the fraction of biotin-modified anchoring RNA (RNAS-biotin) versus biotin-free 
RNA (RNAS) (Table V-1) during the assembly step linearly determined the 
streptavidin coverage level (Figure V-2A), indicating that biotin modification is 
important for optimizing streptavidin loading. Dark field imaging of HRSTs in both 
HeLa and H9 cells showed that the amount of HRSTs in each cell improved with  
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Figure V-2. Increasing level of streptavidin coverage yields enhancing 
efficiency of cellular internalization of TAT peptide-coated HGN-siRNA 
(HRST). A) Levels of streptavidin coverage (I - IV) on HGNs obtained by 
varying input ratios RNAS to RNAS-biotin at the anchoring RNA assembly 
step. B) Dark-field images of HeLa cells (top panel, cell confluence ~100%) and 
hESC H9 cells (bottom panel) internalized with HRSTs of different levels of 
streptavidin coverage. Golden puncta: HRST; Purple: nuclei by Hoechst 
staining.  
 
the increase of streptavidin coverage (Figure V-2B). This supports the use of 
streptavidin as a modular connector for TAT peptides that can be optimized to 
deliver functional RNA into cells. 
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D. Direct linkage of streptavidin blocks siRNA function 
Figure V-3. The fraction of biotinylated siRFP versus unmodified siRFP on 
HRSTs is optimized for the best gene silencing effect. Fluorescence images are 
taken for RFP-expressing HeLa cells three days after HRSTs internalization 
and NIR laser irradiation. HRSTs are treated with different input ratios of 
RFP sense strand (RFPS) to biotinylated RFP sense strand (RFPS-biotin) (1:0, 
2:1, 1:1 and 0:1) for anchoring strand assembly. Cell confluence in images are 
~100%. 
		
Different ratios of the biotinylated sense strand (RFPS-biotin, Table V-1) to 
biotin-free sense strand (RFPS) for RFP-siRNA (siRFP) were assembled on HGNs 
followed by the hybridization of the anti-sense strand (RFPAS) to form siRNA 
duplexes (Figure V-3). HRSTs thus generated with varying levels of streptavidin 
coverage were tested for RFP (mCherry) gene silencing in transduced HeLa cells 
from light-activated siRNA delivery (Figure V-3). Interestingly, the best RFP gene 
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knockdown did not occur for the condition of HRSTs with the highest streptavidin 
coverage (non-biotin : biotin, 0:1) (Figure V-3). Instead, at a fixed amount of RFP-
siRNA loading, the condition with moderate coverage of streptavidin on HRSTs 
(1:1) yielded the best gene knockdown (Figure V-3). We hypothesized that 
streptavidin may block the RNAi machinery from accessing the siRNA duplexes 
which are directly connected to streptavidin, even after the release from the HGN 
surface. However, we still observed gene knockdown activity using HRSTs with 
the maximum streptavidin coverage (Figure V-3, 0:1), suggesting either steric 
effects are incomplete or not all siRNA-biotin carry streptavidin. 
Figure V-4. siRNA sequences (siGFP and siRFP) designed for GFP and 
RFP silencing specifically target respective gene without interfering each other 
in GFP and RFP co-transduced HeLa cells. Thus, siGFP sequence is also used 
as non-sense oligonucleotide strand for RFP. 
		
To investigate this further, we mixed biotin-free non-sense double strand 
RNA (non-sense dsRNA to the RFP gene, Figure V-4) with biotin-modified siRFP, 
so that most or all of the siRFP on surface would carry streptavidin (Figure V-5, 1:1 
and 1:5). As expected, we did not observe any silencing activity from this treatment  
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Figure V-5. The direct linking of streptavidin and TAT peptide to siRNA 
prevents RNAi knockdown. Fluorescence imaging of RFP-expressing HeLa 
cells three days after the internalization of HRSTs and NIR laser irradiation. 
HRSTs are treated with different input ratios of from different input ratios of 
nsRNAS to RFPS-biotin strand (1:1 and 1:5) during the assembly step. Cell 
confluence in images are all ~100%. 
		
(Figure V-5). This result demonstrates that the siRNA activity is blocked by direct 
conjugation to streptavidin. Thus, we conclude that the best siRNA delivery 
strategy is the collective effect from both unmodified siRNA loading and 
biotinylated RNA for streptavidin attachment which can be easily optimized for a 
specific target gene and cell line. 
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E. Optimal cell internalization requires a hybridized RNA-biotin handle 
Figure V-6. The modular handle for streptavidin attaching requires to be 
hybridized for maximum cell penetration and siRNA activity. A) Schematic of 
the modular-designed HRSTs with the non-hybridized (NH, left) and RNAC-
hybridized (right) cell internalization moiety (RNAS-biotin). RNAS-biotin and 
sense strand for GFP-siRNA (siGFP) are assembled on HGNs with the input 
ratio of 5:1. B) Dark-field images of HeLa cells (top panel) and hESC H9 cells 
(bottom panel) internalized with the two types of HRSTs (Golden puncta: 
HRSTs, Blue: Nuclei by Hoechst staining). C) Flow cytometry quantification of 
GFP level in GFP-expressing HeLa cells three days after the internalization of 
the two types of HRSTs and laser irradiation. **, p < 0.01; NS, not significant. 
		
To increase the ease and versatility of the delivery to other sequences of 
siRNA or functional small nucleic acids, we designed a modular surface 
arrangement (Figure V-6A). A universal nucleic acid handle with biotin 
modification for streptavidin and peptide attachment (RNAS-biotin) shares the 
nanoparticle surface with a functional RNA (siGFP) without biotin modification. 
The sequence of each is unique to allow separate examination of each part with 
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regard to cell internalization and gene regulation efficiency. Importantly, HRSTs 
with non-hybridized RNAS-biotin strand showed much lower penetration in both 
HeLa cells and hESC H9 cells (Figure V-6B). Because the gene (GFP) knockdown 
effect was increased in line with the degree of cell internalization (Figure V-6C), 
there is a modular independence between the biotin module for cellular uptake and 
the siGFP module that dictates gene regulation. 
Figure V-7. Relative streptavidin coverage level of HRSTs with the 
modular handle hybridized by RNAC, compared to non-hybridized (NH). 
Relative streptavidin coverage level is estimated by a fluorescence-based 
quantification of Oregon Green 488-labeled neutravidin. 
		
HRSTs with non-hybridized RNAS-biotin show only 60% of the 
streptavidin levels compared to those particles which have been hybridized with 
RNA (Figure V-7), suggesting inefficient presentation of biotin by the streptavidin 
binding RNA module. This is likely due to the high flexibility of single strand 
RNA, which can even cause cross-linking between RNAS-biotin strands by 
streptavidin. However, directly coating HGNs with nucleic acid duplexes results in 
instability and loading difficulties [35]. Notably, our modular assembly involves the 
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deposition of single stranded RNA to maximize attachment density on the surface, 
followed by hybridization, yielding rigid double strands that presented biotin more 
efficiently for streptavidin and TAT peptide coating (see Figure V-6). 
F. RNA hybridizes more efficiently than DNA on HGN surfaces 
Figure V-8. RNA more than doubles the efficiency of DNA hybridization to 
the modular handle for effective cellular uptake. A), B) Dark field image 
quantification of HeLa and H9 cell internalization of HRSTs with the modular 
handle hybridized by DNAC or RNAC. C) Flow cytometry quantification of 
GFP expression level in GFP-expressing HeLa cells three days after the 
internalization of HRSTs (DNAC and RNAC) and laser irradiation. **, p < 
0.01; ***, p < 0.001; NS, not significant.  
		
The replacement of complementary DNA for hybridizing to the scaffold 
RNA handle (RNAS-biotin) would reduce costs of this approach. However, we 
noticed that the hybridization with complementary DNA (DNAC) yielded only half 
of the cell penetration efficiency compared to those hybridized with RNAC at the 
same concentration, observed for both HeLa and H9 cells (Figure V-8A,B). 
Interestingly, RNAC did not show more GFP gene knockdown effects than with 
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DNAC (Figure V-8C), presumably, due to the saturated silencing of GFP gene in 
HeLa cells at the siRNA dosage. The improved cellular delivery of functional RNA 
we explored here, using double stranded RNA as a scaffold for the streptavidin 
targeting moiety, would nevertheless aid future gene regulation applications that 
require high doses of functional RNA. 
Figure V-9. Comparison of duplex number per particle for HGNs 
assembled and hybridized by oligonucleotides of different types (DNA or 
RNA) with identical sequences for 0.5 hour or 3 hours. 
		
To explore the difference in the hybridization efficiency between DNA and 
RNA on the gold nanoparticle surface, we assembled thiolated DNA and RNA of 
identical sequence (T to U) (Table V-1), then hybridized with DNA and RNA of 
complementary sequence (Figure V-9). Fluorescence-based quantification after 
KCN etching showed that the amount of RNA-RNA (RR) duplex was more than 
double that of the DNA-DNA (DD) duplex and RNA-DNA duplex (thiolated RNA 
and complementary DNA, RD) (Figure V-9). We observed the same trend as we 
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extended the hybridization incubation time from 30 minutes to 3 hours (Figure V-
9), indicating that this discrepancy was not due to differing hybridization kinetics. 
Computational algorithms (DINAMelt Web Server) show that RR has a delta G of -
67.0 kcal/mol and Tm of 89.6oC, wheras for DD are -49.6 kcal/mol and 81.0oC. 
Previous experimental studies also report that RR is thermodynamically more stable 
than DD or RD in bulk solution [36-39], as the A-form conformation of RR and RD 
have modestly better base-stacking energy than the B-form DD. However, given 
that HGN surface is densely decorated with oligonucleotides [17], these differences 
are affected by steric, electrostatic hindrance and conformational restriction of the 
surface-tethered strands [40]. The greater flexibility of RNA relative to DNA may 
also contribute to the higher efficiency of RNA hybridization and assembly on 
surface. 
The modular design utilized two types of RNA strands of different 
sequence: one must be hybridized with complementary RNA to form the functional 
siRNA, while the other strand, carrying biotin, can be hybridized by complementary 
DNA or RNA to control the attachment of streptavidin. Using the mixed modular 
RNA surface, we found that the amount of complementary DNA that hybridized to 
one sequence was less when the other sequence had formed RNA/RNA duplexes 
(Figure V-10). The opposite condition, when DNA was added at high concentration 
(up to 150 µM) did not decrease the hybridization efficiency of complementary 
RNA (Figure V-10). This suggests that RNA strands are better hybridized on highly 
compact HGN surfaces. 
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Figure V-10. RNA strands have advantageous hybridization in highly 
compact HGN surface compared to a relatively low affinity of the DNA 
strands. A), B) Amount of Q-labeled duplex number per particle from 
different hybridization strategies shown in the cartoon when RNAS-1 and 
RNAS-2 are co-assembled on HGNs with the input at 2.25 µM and 0.75 µM, 
respectively. **, p < 0.01; ***, p < 0.001; ns, not significant. 
 
G. Summary 
We have developed a modular surface design using gold nanocarriers for the 
efficient delivery of functional short oligonucleotides (here siRNA) applicable to a 
broad spectrum of cell lines (from cancer to stem cells). Streptavidin is introduced 
as a universal handle for cell penetrating peptide coating and the insulator between 
negative-charged oligonucleotides and positive-charged TAT to avoid nanoparticle 
aggregation. To avoid the steric inhibition of direct-linked streptavidin to RNA 
interfering process, HGN surface loaded RNAs are designed into two categories: 
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one for functional small interfering RNAs or other short nucleic acids; the other as 
scaffolds for presenting the biotin to capture streptavidin and the TAT peptide. 
RNA is an ideal choice as surface scaffold, since single strand RNA with high 
flexibility can be densely packed on gold surface through a low-pH induced self-
assembly method and later be hybridized as high affinity duplexes for more 
efficient biotin modification presentation than for single stranded RNA. The 
effective presentation of biotin followed by adequate streptavidin loading yielded 
particles with an optimal level of cell penetration. Furthermore, we found that RNA 
hybridization capacity on HGNs was approximately double of that for DNA 
hybridization, attributed to greater stability of the RNA/RNA duplex. Altogether, 
this work successfully builds a coherent framework between modular nucleic acid 
and targeting peptide surface chemistries. Optimized assemblies can provide 
important insights, applicable to future high-density structures built from functional 
short oligonucleotides, for example, to deliver gRNA for CRISPR, miRNA, anti-
sense DNA, important to emerging areas in genetic control and bioengineering.	
H. Materials and methods 
1. Cell culture 
HeLa and HEK293T cells (ATCC) were cultured in DMEM (Hyclone) 
supplemented with 10% fetal bovine serum (FBS, Hyclone) at 37 ˚C in 5% CO2 
atmosphere. hESC H9 (passage 60-70, WiCell Research Institute) were maintained 
on Matrigel (BD Biosciences) coated plates (BD Falcon) in mTeSR1 medium 
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(Stem Cell Technologies). 50 µg/mL Normocin (InvivoGen) was supplemented in 
cell culture medium.	
2. Generation of stably transduced HeLa cells 
Stably transduced HeLa cells were generated through the lentiviral 
transfection method. Vectors including pLVTHM-scramble (containing an eGFP 
tag, a gift from Dr. Zach Ma, UCSB) and pLV-mCherry (Addgene #36084) were 
used to transduce GFP and RFP gene to HeLa cells respectively. Viral particles 
were generated using the protocol described in Chapter III-H (2). HeLa cells with 
the best transfection efficiency were passaged for 3 times and sorted through FACS 
(BD FACS Aria 2 with a 100 µm nozzle) to collect cells with high and homogenous 
expression of GFP or RFP protein. Stably transduced cells were freeze-stocked and 
used for HGN-mediated siRNA delivery tests. 
3. Nanoparticle preparation, transfection and laser irradiation 
Nanoparticle preparation protocols including HGN synthesis, siRNA 
loading and TAT peptide functionalization are described in Chapter II-H (1-3) and 
Chapter III-H (4). The siRNA sequences (siGFP and siRFP) for GFP and mCherry 
gene knockdown are listed in Table V-1. For HGNs assembled with biotin pre-
modified oligonucleotides, the step of amine group functionalization using NHS-
PEG4-Biotin described in Chapter III-H (4) was skipped. 
HeLa cells on a 6-well plate were harvested by the incubation with 500 µL 
non-enzymatic cell dissociation buffer (CDB, Invitrogen) at 37˚C in 5% CO2 
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atmosphere for 10-15 minutes. Cells were centrifuged at 1000×g for 10 min and re-
suspended in DMEM medium (with 10% FBS supplemented) to a final 
concentration of 1×106 cells/mL. 6.5 pM of coated HGN were added to 200 µL of 
cell suspension and incubated in 1.5 mL Eppendorf tubes at RT for 2 hours on a 
rotator. Free nanoparticles were washed out by adding 1.2 mL DPBS (Invitrogen) 
and centrifuging at 55×g for 5 minutes. 45 µL DPBS was mixed with the cell pellet 
and irradiated for 15 s under pulsed NIR laser (2.4 W/cm2) output from the 
femtosecond (fs) Ti:sapphire regenerative amplifier (Spectraphysics Spitfire) with 
the setup described in Chapter II-H (8). Cells were then further cultured for 3 days 
in 12-well plates at 37oC in 5% CO2 atmosphere, and assessed the fluorescence 
protein expression (GFP and RFP) through microscope imaging (Olympus IX70 
inverted microscope equipped with a QImaging Retiga-2000R Fast 1394 camera) 
and flow cytometry (BD Accuri C6). 
4. Flow cytometry analysis 
Cells on 12-well plates were suspended by incubating with 0.25% trypsin-
EDTA (Thermo SCIENTIFIC, #25200) at 37˚C in a 5% CO2 atmosphere for 5 
minutes, and resuspended in cold DPBS at 1×106 cells/mL. Cells were then injected 
into a BD Accuri C6 flow cytometer with a flow rate of 14 µL/min. A gate area was 
selected from the forward versus side scatter plots, and 10,000 events were 
collected for each sample.	
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5. Dark field imaging 
HeLa cells on an 8-well chamber glass slide (Lab-Tek II), or hESC H9 cells 
on a Matrigel-coated 4-well chamber Permanox slide (Lab-Tek #70400), were 
incubated with 6.5 pM HGNs in DMEM or mTeSR1 medium (with 10% FBS 
supplemented) at 37 ˚C in 5% CO2 atmosphere for 2 hours. Following the twice 
washing by PBS, cells were fixed using 4% paraformaldehyde (VWR International, 
LLC), and washed again in PBS. Cells were then stained the nuclei by Hoechst 
33342 (Sigma-Aldrich) and mounted with Gel/Mount (Electron Microscopy 
Science). Dark-field scattering images were taken using an Olympus BX51 upright 
microscope with the protocol described in Chapter III-H (6). Dark field images 
were quantified the average HGN signals in cells by pixel analysis using ImageJ 
software.	
6. Fluorescence-based quantification of attached molecules 
Through a fluorescence-based assay, Quassar570-labeled oligonucleotides 
(Table V-1) were used to quantify the amount of assembled duplexes on HGNs, and 
Oregon Green 488-labeled neutravidin was used to estimate the relative level of 
streptavidin due to the high biochemical similarity between the two. Oregon Green 
488-labeled neutravidin was prepared by incubating 5 mg/mL neutravidin (Pierce 
#31050) with 0.75 mM Oregon Green 488 NHS ester (10 mM in DMSO, Pierce 
#O6147) in the reaction buffer (1× PBS, 0.75% sodium bicarbonate, 10% glycerol) 
for 3 hours at RT, followed by the twice dialysis (20 KDa Slide-A-Lyzer, Pierce) in 
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1× PBS supplemented with 2 mM NaN3 and filtration (Millipore 0.22 µm 
#SLGV013SL).  
HGNs with fluorescence labels were etched by KCN solution (0.1 M KCN, 
1mM K3Fe(CN)6) to completely release the coated molecules. The standard linear 
calibration curves were generated between the concentrations of fluorescence-
labeled molecules and the corresponding fluorescence intensity detected from a 
Tecan infinite 200 plate reader. The fluorescence signal in solution released from 
HGNs by KCN etching was converted to oligonucleotide duplex unit and 
neutravidin number using the calibration curve.	
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I. Appendix 
Table V-1. Oligonucleotides used. 
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